Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-1|1|503|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-2|1|648|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-3|1|651|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-4|1|677|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-5|1|680|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-6|1|694|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-7|1|715|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-8|1|715|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-9|1|732|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-10|1|745|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-11|1|752|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-12|1|757|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-13|1|765|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-14|1|771|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-15|1|780|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-16|1|782|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-17|1|794|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-18|1|796|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-19|1|796|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-20|1|796|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-21|1|798|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-22|1|802|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-23|1|806|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-24|1|827|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-25|1|836|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-26|1|838|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-27|1|839|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-28|1|848|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-29|1|849|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-30|1|857|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-31|1|859|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-32|1|868|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-33|1|869|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-34|1|869|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-35|1|871|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-36|1|873|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-37|1|873|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-38|1|880|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-39|1|884|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-40|1|884|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-41|1|905|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-42|1|911|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-43|1|911|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-44|1|911|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-45|1|912|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-46|1|913|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-47|1|918|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-48|1|919|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-49|1|920|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-50|1|925|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-51|1|926|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-52|1|928|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-53|1|929|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-54|1|933|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-55|1|934|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-56|1|935|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-57|1|939|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-58|1|942|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-59|1|942|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-60|1|943|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-61|1|946|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-62|1|946|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-63|1|947|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-64|1|948|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-65|1|949|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-66|1|950|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-67|1|951|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-68|1|956|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-69|1|956|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-70|1|956|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-71|1|956|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-72|1|961|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-73|1|962|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-74|1|963|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-75|1|966|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-76|1|970|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-77|1|972|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-78|1|979|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-79|1|980|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-80|1|985|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-81|1|989|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-82|1|992|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-83|1|994|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-84|1|996|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-85|1|996|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-86|1|997|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-87|1|998|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-88|1|1001|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-89|1|1009|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-90|1|1009|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-91|1|1011|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-92|1|1014|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-93|1|1016|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-94|1|1017|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-95|1|1023|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-96|1|1023|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-97|1|1026|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-98|1|1027|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-99|1|1030|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-100|1|1033|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-101|1|1040|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-102|1|1041|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-103|1|1044|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-104|1|1047|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-105|1|1048|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-106|1|1049|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-107|1|1051|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-108|1|1051|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-109|1|1057|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-110|1|1058|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-111|1|1062|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-112|1|1064|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-113|1|1065|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-114|1|1066|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-115|1|1067|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-116|1|1068|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-117|1|1075|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-118|1|1076|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-119|1|1079|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-120|1|1081|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-121|1|1083|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-122|1|1086|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-123|1|1092|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-124|1|1094|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-125|1|1094|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-126|1|1099|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-127|1|1100|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-128|1|1101|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-129|1|1107|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-130|1|1110|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-131|1|1110|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-132|1|1113|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-133|1|1114|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-134|1|1117|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-135|1|1119|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-136|1|1121|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-137|1|1121|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-138|1|1121|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-139|1|1129|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-140|1|1131|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-141|1|1135|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-142|1|1143|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-143|1|1144|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-144|1|1150|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-145|1|1160|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-146|1|1163|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-147|1|1166|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-148|1|1166|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-149|1|1170|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-150|1|1170|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-151|1|1172|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-152|1|1177|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-153|1|1177|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-154|1|1185|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-155|1|1191|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-156|1|1194|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-157|1|1204|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-158|1|1209|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-159|1|1219|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-160|1|1219|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-161|1|1223|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-162|1|1225|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-163|1|1228|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-164|1|1229|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-165|1|1233|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-166|1|1236|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-167|1|1240|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-168|1|1243|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-169|1|1255|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-170|1|1262|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-171|1|1265|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-172|1|1268|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-173|1|1273|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-174|1|1275|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-175|1|1275|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-176|1|1277|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-177|1|1285|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-178|1|1289|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-179|1|1295|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-180|1|1299|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-181|1|1299|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-182|1|1300|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-183|1|1310|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-184|1|1310|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-185|1|1320|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-186|1|1323|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-187|1|1324|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-188|1|1327|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-189|1|1331|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-190|1|1333|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-191|1|1338|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-192|1|1345|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-193|1|1347|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-194|1|1359|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-195|1|1387|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-196|1|1390|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-197|1|1399|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-198|1|1403|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-199|1|1424|n/a|n/a|n/a|
1003-26-1|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xc 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 935 ± 13 lifespan study|1003-26-1-200|1|1429|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-1|2|403|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-2|2|500|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-3|2|509|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-4|2|522|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-5|2|540|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-6|2|560|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-7|2|565|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-8|2|595|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-9|2|604|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-10|2|613|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-11|2|625|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-12|2|670|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-13|2|670|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-14|2|680|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-15|2|687|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-16|2|690|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-17|2|702|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-18|2|705|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-19|2|712|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-20|2|717|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-21|2|718|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-22|2|726|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-23|2|729|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-24|2|737|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-25|2|742|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-26|2|761|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-27|2|773|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-28|2|788|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-29|2|792|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-30|2|796|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-31|2|807|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-32|2|809|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-33|2|822|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-34|2|827|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-35|2|837|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-36|2|837|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-37|2|841|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-38|2|843|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-39|2|844|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-40|2|845|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-41|2|846|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-42|2|848|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-43|2|848|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-44|2|849|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-45|2|854|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-46|2|862|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-47|2|862|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-48|2|865|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-49|2|866|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-50|2|868|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-51|2|872|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-52|2|876|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-53|2|877|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-54|2|880|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-55|2|890|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-56|2|892|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-57|2|896|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-58|2|897|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-59|2|907|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-60|2|911|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-61|2|912|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-62|2|918|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-63|2|921|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-64|2|921|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-65|2|922|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-66|2|926|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-67|2|926|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-68|2|928|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-69|2|934|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-70|2|937|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-71|2|940|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-72|2|942|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-73|2|946|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-74|2|946|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-75|2|946|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-76|2|953|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-77|2|960|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-78|2|960|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-79|2|967|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-80|2|968|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-81|2|974|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-82|2|976|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-83|2|977|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-84|2|977|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-85|2|988|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-86|2|988|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-87|2|991|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-88|2|992|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-89|2|992|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-90|2|997|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-91|2|998|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-92|2|999|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-93|2|1002|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-94|2|1002|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-95|2|1003|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-96|2|1003|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-97|2|1005|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-98|2|1006|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-99|2|1008|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-100|2|1010|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-101|2|1011|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-102|2|1012|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-103|2|1013|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-104|2|1017|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-105|2|1019|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-106|2|1020|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-107|2|1022|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-108|2|1023|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-109|2|1024|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-110|2|1030|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-111|2|1030|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-112|2|1030|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-113|2|1031|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-114|2|1036|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-115|2|1037|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-116|2|1039|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-117|2|1046|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-118|2|1047|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-119|2|1051|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-120|2|1052|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-121|2|1052|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-122|2|1053|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-123|2|1058|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-124|2|1060|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-125|2|1062|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-126|2|1064|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-127|2|1065|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-128|2|1068|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-129|2|1073|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-130|2|1074|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-131|2|1077|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-132|2|1079|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-133|2|1080|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-134|2|1081|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-135|2|1082|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-136|2|1082|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-137|2|1082|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-138|2|1082|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-139|2|1086|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-140|2|1086|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-141|2|1091|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-142|2|1102|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-143|2|1104|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-144|2|1107|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-145|2|1112|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-146|2|1114|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-147|2|1115|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-148|2|1118|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-149|2|1121|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-150|2|1121|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-151|2|1137|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-152|2|1146|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-153|2|1148|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-154|2|1149|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-155|2|1152|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-156|2|1153|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-157|2|1163|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-158|2|1164|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-159|2|1166|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-160|2|1168|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-161|2|1171|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-162|2|1174|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-163|2|1175|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-164|2|1180|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-165|2|1184|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-166|2|1184|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-167|2|1195|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-168|2|1197|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-169|2|1200|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-170|2|1204|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-171|2|1208|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-172|2|1210|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-173|2|1212|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-174|2|1214|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-175|2|1216|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-176|2|1217|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-177|2|1217|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-178|2|1220|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-179|2|1229|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-180|2|1229|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-181|2|1235|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-182|2|1236|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-183|2|1242|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-184|2|1246|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-185|2|1248|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-186|2|1251|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-187|2|1254|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-188|2|1254|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-189|2|1256|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-190|2|1257|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-191|2|1264|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-192|2|1267|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-193|2|1277|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-194|2|1281|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-195|2|1301|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-196|2|1304|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-197|2|1332|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-198|2|1346|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-199|2|1359|n/a|n/a|n/a|
1003-26-2|n/a,XO|1|100|shamexposed|0|milli grays|External exposure|code Xo 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|199 records survival 891 ± 14 lifespan study|1003-26-2-200|2|1421|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-1|3|239|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-2|3|387|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-3|3|452|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-4|3|502|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-5|3|597|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-6|3|604|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-7|3|614|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-8|3|632|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-9|3|635|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-10|3|645|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-11|3|647|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-12|3|652|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-13|3|669|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-14|3|673|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-15|3|680|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-16|3|715|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-17|3|725|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-18|3|745|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-19|3|751|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-20|3|752|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-21|3|758|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-22|3|760|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-23|3|767|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-24|3|779|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-25|3|785|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-26|3|793|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-27|3|796|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-28|3|799|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-29|3|803|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-30|3|803|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-31|3|806|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-32|3|807|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-33|3|809|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-34|3|813|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-35|3|815|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-36|3|816|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-37|3|817|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-38|3|819|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-39|3|820|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-40|3|820|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-41|3|823|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-42|3|824|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-43|3|827|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-44|3|827|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-45|3|828|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-46|3|829|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-47|3|834|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-48|3|838|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-49|3|841|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-50|3|841|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-51|3|842|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-52|3|848|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-53|3|850|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-54|3|851|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-55|3|857|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-56|3|859|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-57|3|865|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-58|3|870|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-59|3|873|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-60|3|880|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-61|3|883|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-62|3|890|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-63|3|893|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-64|3|894|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-65|3|897|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-66|3|899|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-67|3|901|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-68|3|903|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-69|3|907|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-70|3|911|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-71|3|913|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-72|3|913|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-73|3|914|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-74|3|914|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-75|3|914|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-76|3|918|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-77|3|918|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-78|3|918|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-79|3|918|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-80|3|918|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-81|3|919|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-82|3|919|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-83|3|920|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-84|3|921|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-85|3|931|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-86|3|932|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-87|3|934|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-88|3|934|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-89|3|936|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-90|3|939|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-91|3|941|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-92|3|954|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-93|3|957|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-94|3|960|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-95|3|961|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-96|3|963|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-97|3|969|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-98|3|970|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-99|3|971|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-100|3|973|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-101|3|973|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-102|3|975|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-103|3|979|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-104|3|980|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-105|3|981|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-106|3|982|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-107|3|982|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-108|3|983|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-109|3|988|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-110|3|992|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-111|3|992|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-112|3|993|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-113|3|994|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-114|3|995|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-115|3|995|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-116|3|1002|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-117|3|1004|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-118|3|1010|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-119|3|1013|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-120|3|1023|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-121|3|1027|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-122|3|1030|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-123|3|1031|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-124|3|1032|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-125|3|1032|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-126|3|1040|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-127|3|1040|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-128|3|1042|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-129|3|1046|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-130|3|1046|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-131|3|1051|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-132|3|1052|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-133|3|1052|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-134|3|1053|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-135|3|1056|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-136|3|1058|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-137|3|1058|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-138|3|1061|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-139|3|1062|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-140|3|1065|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-141|3|1067|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-142|3|1068|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-143|3|1069|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-144|3|1072|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-145|3|1076|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-146|3|1085|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-147|3|1089|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-148|3|1093|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-149|3|1095|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-150|3|1096|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-151|3|1100|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-152|3|1109|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-153|3|1111|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-154|3|1113|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-155|3|1114|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-156|3|1126|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-157|3|1127|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-158|3|1132|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-159|3|1132|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-160|3|1144|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-161|3|1160|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-162|3|1163|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-163|3|1170|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-164|3|1170|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-165|3|1170|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-166|3|1173|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-167|3|1173|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-168|3|1184|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-169|3|1184|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-170|3|1191|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-171|3|1194|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-172|3|1200|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-173|3|1205|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-174|3|1207|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-175|3|1210|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-176|3|1212|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-177|3|1212|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-178|3|1213|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-179|3|1213|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-180|3|1214|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-181|3|1220|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-182|3|1223|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-183|3|1228|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-184|3|1230|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-185|3|1240|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-186|3|1240|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-187|3|1247|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-188|3|1250|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-189|3|1254|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-190|3|1258|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-191|3|1267|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-192|3|1269|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-193|3|1270|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-194|3|1271|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-195|3|1277|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-196|3|1277|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-197|3|1283|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-198|3|1290|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-199|3|1303|n/a|n/a|n/a|
1003-26-3|n/a,XX|1|100|shamexposed|0|milli grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 865 ± 13 lifespan study|1003-26-3-200|3|1401|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-1|4|101|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-2|4|101|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-3|4|101|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-4|4|101|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-5|4|101|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-6|4|147|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-7|4|147|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-8|4|147|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-9|4|147|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-10|4|147|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-11|4|298|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-12|4|436|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-13|4|458|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-14|4|499|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-15|4|500|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-16|4|515|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-17|4|519|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-18|4|520|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-19|4|530|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-20|4|533|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-21|4|564|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-22|4|575|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-23|4|578|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-24|4|578|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-25|4|579|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-26|4|600|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-27|4|604|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-28|4|614|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-29|4|627|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-30|4|628|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-31|4|639|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-32|4|646|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-33|4|648|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-34|4|684|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-35|4|688|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-36|4|701|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-37|4|702|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-38|4|702|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-39|4|703|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-40|4|705|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-41|4|711|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-42|4|714|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-43|4|722|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-44|4|724|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-45|4|726|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-46|4|729|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-47|4|729|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-48|4|743|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-49|4|745|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-50|4|747|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-51|4|752|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-52|4|752|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-53|4|754|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-54|4|757|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-55|4|759|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-56|4|761|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-57|4|767|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-58|4|779|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-59|4|779|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-60|4|780|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-61|4|786|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-62|4|789|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-63|4|791|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-64|4|792|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-65|4|796|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-66|4|799|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-67|4|802|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-68|4|802|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-69|4|806|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-70|4|808|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-71|4|808|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-72|4|811|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-73|4|813|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-74|4|814|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-75|4|816|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-76|4|817|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-77|4|824|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-78|4|829|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-79|4|834|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-80|4|834|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-81|4|836|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-82|4|837|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-83|4|841|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-84|4|848|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-85|4|848|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-86|4|848|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-87|4|850|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-88|4|851|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-89|4|852|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-90|4|854|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-91|4|854|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-92|4|855|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-93|4|862|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-94|4|862|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-95|4|864|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-96|4|865|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-97|4|865|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-98|4|869|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-99|4|870|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-100|4|871|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-101|4|875|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-102|4|877|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-103|4|879|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-104|4|880|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-105|4|880|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-106|4|883|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-107|4|884|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-108|4|884|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-109|4|889|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-110|4|893|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-111|4|894|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-112|4|896|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-113|4|897|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-114|4|898|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-115|4|902|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-116|4|904|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-117|4|904|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-118|4|905|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-119|4|907|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-120|4|908|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-121|4|910|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-122|4|911|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-123|4|912|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-124|4|912|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-125|4|914|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-126|4|918|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-127|4|920|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-128|4|920|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-129|4|921|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-130|4|924|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-131|4|925|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-132|4|925|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-133|4|925|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-134|4|927|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-135|4|928|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-136|4|932|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-137|4|934|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-138|4|936|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-139|4|940|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-140|4|940|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-141|4|941|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-142|4|941|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-143|4|943|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-144|4|946|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-145|4|947|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-146|4|948|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-147|4|950|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-148|4|950|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-149|4|952|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-150|4|953|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-151|4|953|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-152|4|954|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-153|4|954|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-154|4|955|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-155|4|955|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-156|4|957|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-157|4|957|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-158|4|959|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-159|4|970|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-160|4|971|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-161|4|971|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-162|4|971|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-163|4|973|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-164|4|973|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-165|4|974|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-166|4|974|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-167|4|977|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-168|4|978|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-169|4|983|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-170|4|984|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-171|4|985|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-172|4|987|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-173|4|987|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-174|4|988|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-175|4|988|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-176|4|991|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-177|4|995|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-178|4|998|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-179|4|1002|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-180|4|1004|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-181|4|1005|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-182|4|1005|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-183|4|1005|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-184|4|1013|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-185|4|1014|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-186|4|1021|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-187|4|1022|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-188|4|1022|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-189|4|1024|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-190|4|1025|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-191|4|1025|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-192|4|1028|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-193|4|1032|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-194|4|1032|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-195|4|1034|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-196|4|1034|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-197|4|1038|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-198|4|1038|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-199|4|1039|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-200|4|1044|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-201|4|1048|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-202|4|1051|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-203|4|1052|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-204|4|1052|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-205|4|1054|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-206|4|1055|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-207|4|1055|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-208|4|1058|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-209|4|1058|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-210|4|1061|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-211|4|1061|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-212|4|1064|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-213|4|1065|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-214|4|1065|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-215|4|1066|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-216|4|1067|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-217|4|1069|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-218|4|1069|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-219|4|1070|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-220|4|1071|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-221|4|1073|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-222|4|1073|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-223|4|1074|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-224|4|1074|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-225|4|1079|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-226|4|1079|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-227|4|1080|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-228|4|1081|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-229|4|1086|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-230|4|1087|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-231|4|1087|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-232|4|1093|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-233|4|1096|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-234|4|1099|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-235|4|1100|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-236|4|1101|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-237|4|1101|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-238|4|1106|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-239|4|1107|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-240|4|1110|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-241|4|1110|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-242|4|1111|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-243|4|1113|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-244|4|1114|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-245|4|1116|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-246|4|1119|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-247|4|1119|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-248|4|1122|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-249|4|1129|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-250|4|1130|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-251|4|1133|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-252|4|1135|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-253|4|1142|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-254|4|1152|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-255|4|1153|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-256|4|1156|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-257|4|1163|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-258|4|1163|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-259|4|1170|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-260|4|1175|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-261|4|1178|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-262|4|1184|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-263|4|1186|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-264|4|1187|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-265|4|1191|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-266|4|1191|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-267|4|1193|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-268|4|1193|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-269|4|1197|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-270|4|1198|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-271|4|1205|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-272|4|1208|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-273|4|1209|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-274|4|1215|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-275|4|1218|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-276|4|1220|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-277|4|1230|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-278|4|1233|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-279|4|1233|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-280|4|1240|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-281|4|1244|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-282|4|1247|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-283|4|1247|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-284|4|1248|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-285|4|1259|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-286|4|1261|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-287|4|1268|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-288|4|1282|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-289|4|1283|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-290|4|1286|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-291|4|1290|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-292|4|1292|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-293|4|1310|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-294|4|1314|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-295|4|1316|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-296|4|1330|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-297|4|1331|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-298|4|1373|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-299|4|1408|n/a|n/a|n/a|
1003-26-4|n/a,X2|1|100|neutrons fission|0.05|grays|External exposure|code X2 1 fraction 20 m|300 (300 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|289 records survival 850 ± 12 lifespan study|1003-26-4-300|4|1437|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-1|5|432|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-2|5|452|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-3|5|470|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-4|5|527|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-5|5|553|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-6|5|564|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-7|5|577|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-8|5|607|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-9|5|631|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-10|5|645|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-11|5|648|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-12|5|668|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-13|5|680|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-14|5|694|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-15|5|694|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-16|5|703|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-17|5|706|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-18|5|712|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-19|5|717|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-20|5|721|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-21|5|722|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-22|5|731|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-23|5|731|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-24|5|747|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-25|5|747|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-26|5|771|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-27|5|772|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-28|5|772|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-29|5|773|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-30|5|781|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-31|5|799|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-32|5|810|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-33|5|814|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-34|5|814|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-35|5|817|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-36|5|821|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-37|5|823|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-38|5|823|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-39|5|827|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-40|5|830|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-41|5|834|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-42|5|834|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-43|5|837|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-44|5|837|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-45|5|837|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-46|5|839|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-47|5|841|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-48|5|841|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-49|5|842|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-50|5|844|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-51|5|850|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-52|5|851|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-53|5|851|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-54|5|852|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-55|5|855|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-56|5|855|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-57|5|860|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-58|5|870|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-59|5|870|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-60|5|878|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-61|5|884|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-62|5|886|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-63|5|890|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-64|5|891|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-65|5|892|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-66|5|892|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-67|5|897|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-68|5|898|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-69|5|898|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-70|5|903|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-71|5|904|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-72|5|904|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-73|5|912|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-74|5|918|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-75|5|926|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-76|5|934|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-77|5|935|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-78|5|940|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-79|5|945|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-80|5|947|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-81|5|953|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-82|5|956|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-83|5|960|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-84|5|962|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-85|5|964|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-86|5|969|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-87|5|970|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-88|5|971|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-89|5|972|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-90|5|975|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-91|5|978|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-92|5|979|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-93|5|981|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-94|5|982|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-95|5|983|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-96|5|984|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-97|5|984|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-98|5|985|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-99|5|988|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-100|5|996|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-101|5|999|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-102|5|1001|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-103|5|1005|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-104|5|1007|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-105|5|1011|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-106|5|1016|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-107|5|1018|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-108|5|1018|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-109|5|1020|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-110|5|1025|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-111|5|1025|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-112|5|1026|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-113|5|1030|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-114|5|1035|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-115|5|1040|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-116|5|1041|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-117|5|1043|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-118|5|1044|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-119|5|1045|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-120|5|1048|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-121|5|1052|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-122|5|1058|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-123|5|1060|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-124|5|1065|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-125|5|1067|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-126|5|1071|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-127|5|1072|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-128|5|1072|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-129|5|1072|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-130|5|1073|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-131|5|1074|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-132|5|1076|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-133|5|1077|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-134|5|1079|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-135|5|1079|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-136|5|1086|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-137|5|1086|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-138|5|1089|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-139|5|1090|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-140|5|1100|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-141|5|1101|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-142|5|1107|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-143|5|1109|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-144|5|1109|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-145|5|1115|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-146|5|1117|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-147|5|1117|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-148|5|1121|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-149|5|1121|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-150|5|1123|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-151|5|1128|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-152|5|1130|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-153|5|1132|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-154|5|1132|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-155|5|1132|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-156|5|1135|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-157|5|1135|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-158|5|1142|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-159|5|1143|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-160|5|1144|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-161|5|1146|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-162|5|1149|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-163|5|1152|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-164|5|1156|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-165|5|1158|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-166|5|1170|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-167|5|1170|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-168|5|1175|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-169|5|1176|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-170|5|1178|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-171|5|1187|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-172|5|1188|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-173|5|1191|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-174|5|1194|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-175|5|1198|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-176|5|1200|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-177|5|1211|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-178|5|1215|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-179|5|1216|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-180|5|1227|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-181|5|1228|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-182|5|1230|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-183|5|1232|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-184|5|1236|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-185|5|1240|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-186|5|1244|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-187|5|1254|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-188|5|1259|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-189|5|1260|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-190|5|1262|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-191|5|1275|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-192|5|1286|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-193|5|1301|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-194|5|1310|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-195|5|1345|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-196|5|1351|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-197|5|1359|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-198|5|1368|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-199|5|1387|n/a|n/a|n/a|
1003-26-5|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|200 records survival 876 ± 14 lifespan study|1003-26-5-200|5|1389|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-1|6|240|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-2|6|500|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-3|6|516|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-4|6|532|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-5|6|596|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-6|6|596|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-7|6|602|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-8|6|621|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-9|6|631|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-10|6|631|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-11|6|633|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-12|6|663|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-13|6|667|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-14|6|682|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-15|6|684|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-16|6|689|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-17|6|694|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-18|6|702|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-19|6|710|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-20|6|710|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-21|6|712|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-22|6|715|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-23|6|715|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-24|6|722|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-25|6|723|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-26|6|724|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-27|6|725|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-28|6|736|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-29|6|739|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-30|6|740|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-31|6|740|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-32|6|750|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-33|6|752|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-34|6|754|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-35|6|757|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-36|6|759|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-37|6|761|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-38|6|767|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-39|6|771|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-40|6|777|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-41|6|778|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-42|6|789|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-43|6|793|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-44|6|796|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-45|6|801|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-46|6|805|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-47|6|807|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-48|6|808|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-49|6|809|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-50|6|814|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-51|6|814|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-52|6|822|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-53|6|822|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-54|6|824|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-55|6|826|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-56|6|827|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-57|6|828|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-58|6|828|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-59|6|829|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-60|6|833|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-61|6|836|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-62|6|836|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-63|6|837|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-64|6|841|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-65|6|841|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-66|6|842|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-67|6|842|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-68|6|847|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-69|6|851|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-70|6|856|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-71|6|859|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-72|6|865|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-73|6|865|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-74|6|869|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-75|6|870|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-76|6|871|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-77|6|871|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-78|6|875|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-79|6|876|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-80|6|880|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-81|6|880|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-82|6|887|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-83|6|891|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-84|6|893|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-85|6|896|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-86|6|904|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-87|6|905|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-88|6|907|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-89|6|907|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-90|6|908|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-91|6|911|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-92|6|913|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-93|6|914|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-94|6|918|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-95|6|918|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-96|6|922|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-97|6|922|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-98|6|924|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-99|6|928|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-100|6|929|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-101|6|936|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-102|6|940|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-103|6|941|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-104|6|943|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-105|6|943|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-106|6|944|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-107|6|948|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-108|6|954|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-109|6|960|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-110|6|962|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-111|6|965|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-112|6|976|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-113|6|977|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-114|6|981|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-115|6|985|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-116|6|992|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-117|6|995|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-118|6|996|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-119|6|997|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-120|6|999|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-121|6|1003|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-122|6|1003|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-123|6|1006|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-124|6|1009|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-125|6|1009|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-126|6|1010|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-127|6|1010|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-128|6|1011|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-129|6|1011|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-130|6|1012|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-131|6|1016|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-132|6|1016|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-133|6|1017|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-134|6|1018|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-135|6|1019|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-136|6|1020|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-137|6|1024|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-138|6|1025|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-139|6|1028|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-140|6|1030|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-141|6|1030|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-142|6|1031|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-143|6|1032|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-144|6|1032|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-145|6|1032|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-146|6|1033|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-147|6|1043|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-148|6|1044|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-149|6|1046|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-150|6|1051|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-151|6|1052|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-152|6|1057|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-153|6|1059|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-154|6|1059|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-155|6|1060|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-156|6|1070|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-157|6|1071|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-158|6|1075|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-159|6|1075|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-160|6|1075|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-161|6|1077|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-162|6|1081|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-163|6|1089|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-164|6|1090|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-165|6|1093|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-166|6|1099|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-167|6|1101|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-168|6|1105|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-169|6|1107|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-170|6|1114|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-171|6|1118|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-172|6|1128|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-173|6|1128|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-174|6|1129|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-175|6|1130|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-176|6|1143|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-177|6|1148|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-178|6|1156|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-179|6|1158|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-180|6|1162|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-181|6|1163|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-182|6|1165|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-183|6|1169|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-184|6|1169|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-185|6|1170|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-186|6|1170|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-187|6|1171|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-188|6|1177|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-189|6|1191|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-190|6|1198|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-191|6|1214|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-192|6|1226|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-193|6|1238|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-194|6|1251|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-195|6|1286|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-196|6|1290|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-197|6|1296|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-198|6|1359|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-199|6|1385|n/a|n/a|n/a|
1003-26-6|n/a,X3|1|100|neutrons fission|0.1|grays|External exposure|code X3 1 fraction 45 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 827 ± 13 lifespan study|1003-26-6-200|6|1478|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-1|7|150|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-2|7|159|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-3|7|159|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-4|7|257|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-5|7|427|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-6|7|471|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-7|7|475|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-8|7|495|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-9|7|522|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-10|7|529|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-11|7|534|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-12|7|548|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-13|7|551|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-14|7|570|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-15|7|617|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-16|7|619|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-17|7|620|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-18|7|620|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-19|7|620|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-20|7|633|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-21|7|640|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-22|7|645|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-23|7|661|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-24|7|666|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-25|7|668|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-26|7|691|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-27|7|691|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-28|7|691|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-29|7|715|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-30|7|725|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-31|7|729|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-32|7|734|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-33|7|734|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-34|7|735|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-35|7|736|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-36|7|744|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-37|7|751|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-38|7|755|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-39|7|757|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-40|7|757|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-41|7|773|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-42|7|784|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-43|7|789|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-44|7|794|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-45|7|795|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-46|7|795|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-47|7|799|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-48|7|808|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-49|7|809|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-50|7|814|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-51|7|814|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-52|7|822|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-53|7|823|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-54|7|823|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-55|7|828|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-56|7|828|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-57|7|829|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-58|7|837|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-59|7|842|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-60|7|849|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-61|7|850|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-62|7|851|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-63|7|857|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-64|7|858|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-65|7|861|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-66|7|862|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-67|7|863|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-68|7|865|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-69|7|869|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-70|7|873|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-71|7|883|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-72|7|884|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-73|7|890|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-74|7|898|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-75|7|900|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-76|7|906|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-77|7|906|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-78|7|911|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-79|7|915|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-80|7|916|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-81|7|918|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-82|7|918|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-83|7|924|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-84|7|929|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-85|7|930|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-86|7|935|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-87|7|943|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-88|7|946|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-89|7|946|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-90|7|948|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-91|7|953|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-92|7|954|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-93|7|954|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-94|7|961|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-95|7|961|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-96|7|964|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-97|7|967|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-98|7|969|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-99|7|969|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-100|7|969|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-101|7|971|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-102|7|974|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-103|7|974|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-104|7|976|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-105|7|981|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-106|7|983|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-107|7|983|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-108|7|988|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-109|7|988|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-110|7|988|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-111|7|990|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-112|7|991|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-113|7|995|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-114|7|997|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-115|7|999|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-116|7|1002|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-117|7|1005|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-118|7|1009|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-119|7|1009|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-120|7|1012|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-121|7|1017|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-122|7|1018|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-123|7|1018|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-124|7|1021|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-125|7|1023|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-126|7|1023|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-127|7|1027|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-128|7|1037|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-129|7|1037|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-130|7|1039|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-131|7|1044|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-132|7|1046|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-133|7|1047|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-134|7|1051|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-135|7|1051|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-136|7|1058|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-137|7|1059|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-138|7|1062|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-139|7|1065|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-140|7|1066|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-141|7|1067|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-142|7|1072|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-143|7|1075|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-144|7|1076|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-145|7|1078|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-146|7|1080|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-147|7|1087|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-148|7|1092|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-149|7|1094|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-150|7|1096|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-151|7|1101|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-152|7|1108|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-153|7|1115|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-154|7|1118|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-155|7|1118|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-156|7|1121|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-157|7|1121|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-158|7|1135|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-159|7|1143|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-160|7|1148|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-161|7|1149|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-162|7|1149|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-163|7|1151|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-164|7|1152|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-165|7|1155|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-166|7|1156|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-167|7|1158|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-168|7|1158|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-169|7|1167|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-170|7|1170|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-171|7|1171|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-172|7|1174|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-173|7|1179|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-174|7|1187|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-175|7|1188|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-176|7|1194|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-177|7|1200|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-178|7|1202|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-179|7|1207|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-180|7|1215|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-181|7|1219|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-182|7|1220|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-183|7|1223|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-184|7|1224|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-185|7|1226|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-186|7|1230|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-187|7|1233|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-188|7|1242|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-189|7|1243|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-190|7|1249|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-191|7|1255|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-192|7|1257|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-193|7|1261|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-194|7|1270|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-195|7|1279|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-196|7|1292|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-197|7|1299|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-198|7|1324|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-199|7|1352|n/a|n/a|n/a|
1003-26-7|n/a,XX|1|100|neutrons fission|0.1|grays|External exposure|code XX 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|197 records survival 846 ± 15 lifespan study|1003-26-7-200|7|1421|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-1|8|115|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-2|8|115|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-3|8|115|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-4|8|115|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-5|8|115|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-6|8|247|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-7|8|257|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-8|8|348|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-9|8|354|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-10|8|378|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-11|8|380|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-12|8|380|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-13|8|463|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-14|8|473|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-15|8|484|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-16|8|490|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-17|8|513|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-18|8|515|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-19|8|516|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-20|8|525|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILT. ADJACENT SKELETAL MUSCLE.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-21|8|528|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-22|8|533|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-23|8|537|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-24|8|539|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-25|8|554|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWM: TMAB INFILTRATION OF MUSCLE & DERMIS.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-26|8|575|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-27|8|592|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MMTA/  Metritis|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-28|8|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSL/  undifferentiated leukemia lymphoret.tissue,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-29|8|596|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-30|8|603|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-31|8|612|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-32|8|613|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-33|8|618|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-34|8|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-35|8|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-36|8|623|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-37|8|624|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-38|8|625|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-39|8|632|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-40|8|632|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-41|8|632|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-42|8|632|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-43|8|632|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-44|8|633|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-45|8|636|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-46|8|637|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-47|8|641|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-48|8|641|Other deterministic changes|Whole body|MCDU/  Eye(s) missing|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-49|8|644|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-50|8|648|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-51|8|648|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-52|8|650|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-53|8|654|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-54|8|655|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-55|8|658|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-56|8|663|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-57|8|663|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-58|8|664|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-59|8|666|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-60|8|668|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILTR. MUSCLE & SKIN.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-61|8|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSS/  undifferentiated lymphoma,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-62|8|669|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-63|8|674|Neoplasia systemic|Haematolymphatic system|TLPS/ metastasis to spleen & lung; around & with all organs.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-64|8|677|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-65|8|678|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-66|8|682|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-67|8|683|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-68|8|684|Other deterministic changes|Whole body|MCDU/  Head/neck missing|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-69|8|685|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-70|8|690|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-71|8|691|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-72|8|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-73|8|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-74|8|710|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-75|8|711|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-76|8|719|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-77|8|721|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-78|8|722|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-79|8|722|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-80|8|723|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-81|8|724|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-82|8|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-83|8|734|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-84|8|734|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-85|8|738|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-86|8|739|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-87|8|739|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-88|8|739|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-89|8|743|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-90|8|743|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-91|8|743|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to musc of thorax. Metastases  trac to pleural & mediastinal regions.,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-92|8|745|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-93|8|746|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-94|8|747|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-95|8|750|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Head/neck missing,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-96|8|752|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-97|8|754|Neoplasia systemic|Haematolymphatic system|TLML/   Metastases Lung|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-98|8|754|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-99|8|756|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWR: TRAC TO MEDIASTINAL TISSUE.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-100|8|757|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-101|8|759|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-102|8|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ leukemia acute.,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-103|8|759|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-104|8|763|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-105|8|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-106|8|765|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-107|8|765|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-108|8|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-109|8|770|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVS/   Metastases Lung,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-110|8|771|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-111|8|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-112|8|773|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/ angiomatous type.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-113|8|778|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-114|8|779|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-115|8|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-116|8|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-117|8|780|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-118|8|782|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-119|8|785|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-120|8|788|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-121|8|788|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-122|8|788|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-123|8|788|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-124|8|789|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSL/  undifferentiated leukemia lymphoret.tissue,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-125|8|790|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXUO/ leiomyoma caecum.,MPATH: 218 - neoplasm|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-126|8|792|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-127|8|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-128|8|794|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-129|8|795|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-130|8|797|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-131|8|798|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-132|8|800|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-133|8|801|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-134|8|803|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-135|8|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-136|8|804|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-137|8|804|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-138|8|806|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-139|8|806|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-140|8|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-141|8|806|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-142|8|806|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-143|8|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-144|8|807|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-145|8|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ w/ leukemia.,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-146|8|808|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lumbar spine.Eye(s) missing|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-147|8|808|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/ with hemorrhage.Head/neck missing,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-148|8|808|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-149|8|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-150|8|809|Other deterministic changes|Whole body|MCDU/  Head/neck missing Eye(s) missing|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-151|8|809|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-152|8|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-153|8|813|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-154|8|813|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-155|8|815|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-156|8|815|Neoplasia benign|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAO/ islet cell-- pancreas.,MPATH: 270 - adenoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-157|8|816|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-158|8|817|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal,MPATH: 218 - neoplasm|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-159|8|818|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-160|8|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-161|8|822|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-162|8|823|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-163|8|824|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-164|8|825|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-165|8|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-166|8|829|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-167|8|829|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-168|8|831|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWR: TRAC TO MEDIASTINAL TISSUE.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-169|8|831|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-170|8|832|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-171|8|833|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-172|8|833|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-173|8|833|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-174|8|834|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-175|8|835|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-176|8|836|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-177|8|836|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-178|8|837|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ with leukemia.,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-179|8|838|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-180|8|838|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-181|8|838|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-182|8|838|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-183|8|842|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC TO PT LN & NUMEROUS OTHER LYMPH NODULES.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-184|8|842|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-185|8|843|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-186|8|843|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-187|8|844|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-188|8|844|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-189|8|844|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-190|8|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-191|8|847|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-192|8|847|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-193|8|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ with leukemia.,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-194|8|849|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-195|8|851|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-196|8|851|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILTR. MUSCLE & SKIN.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-197|8|855|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-198|8|856|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-199|8|856|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-200|8|857|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXUO/ perit fat.,MPATH: 218 - neoplasm|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-201|8|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-202|8|859|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-203|8|860|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-204|8|861|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-205|8|861|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-206|8|862|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ in pelvis.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-207|8|863|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-208|8|863|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-209|8|863|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-210|8|863|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-211|8|864|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-212|8|865|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-213|8|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-214|8|868|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-215|8|869|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-216|8|871|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-217|8|872|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-218|8|875|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-219|8|876|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-220|8|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-221|8|878|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-222|8|878|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-223|8|878|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-224|8|879|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-225|8|879|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-226|8|880|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-227|8|880|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-228|8|881|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-229|8|881|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-230|8|881|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-231|8|882|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-232|8|882|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-233|8|882|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-234|8|882|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-235|8|882|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-236|8|883|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-237|8|883|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-238|8|885|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-239|8|886|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC TO PT LN & NUMEROUS OTHER LYMPH NODULES.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-240|8|886|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-241|8|886|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-242|8|887|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-243|8|888|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases  trac extension into pleura & mediastinum.,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-244|8|888|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-245|8|889|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-246|8|890|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ upper arm. Metastases  Muscle tcvs infiltrates skeletal musc.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-247|8|890|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-248|8|890|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-249|8|890|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-250|8|890|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-251|8|891|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-252|8|892|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-253|8|893|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-254|8|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-255|8|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-256|8|894|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-257|8|895|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-258|8|896|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-259|8|897|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-260|8|897|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-261|8|897|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-262|8|898|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-263|8|898|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-264|8|902|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-265|8|902|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-266|8|903|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut lt lateral trunk.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-267|8|904|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-268|8|905|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-269|8|905|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-270|8|905|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-271|8|906|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-272|8|906|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-273|8|907|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-274|8|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-275|8|909|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-276|8|909|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-277|8|910|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-278|8|910|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-279|8|911|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-280|8|912|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-281|8|914|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-282|8|914|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-283|8|914|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-284|8|916|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-285|8|917|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-286|8|919|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-287|8|919|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-288|8|920|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-289|8|920|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-290|8|920|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-291|8|922|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-292|8|923|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/ with muscle infiltration.Predominantly ductalHead/neck missing Eye(s) missing,MPATH: 218 - neoplasm|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-293|8|925|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-294|8|926|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-295|8|926|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-296|8|926|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-297|8|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-298|8|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-299|8|928|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-300|8|930|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-301|8|930|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-302|8|930|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-303|8|932|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-304|8|935|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-305|8|935|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-306|8|935|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-307|8|939|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-308|8|939|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-309|8|939|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-310|8|940|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-311|8|941|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-312|8|941|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-313|8|941|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILT. OF MUSCLE.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-314|8|941|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-315|8|943|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-316|8|944|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWM: TMAB INFILTRATION OF MUSCLE & DERMIS.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-317|8|944|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-318|8|944|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-319|8|945|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-320|8|945|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-321|8|946|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-322|8|946|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MPNU/  Acute and subacute,MPATH: 212 - inflammation|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-323|8|947|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-324|8|947|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-325|8|947|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-326|8|948|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-327|8|948|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-328|8|948|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-329|8|948|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-330|8|950|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-331|8|950|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-332|8|950|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-333|8|951|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-334|8|952|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-335|8|953|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-336|8|953|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-337|8|954|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-338|8|954|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-339|8|955|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-340|8|956|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-341|8|956|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-342|8|957|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-343|8|957|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-344|8|958|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-345|8|959|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-346|8|960|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-347|8|961|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-348|8|961|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-349|8|961|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOAC/   Metastases  toac to visc perit.,MPATH: 218 - neoplasm|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-350|8|962|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-351|8|962|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-352|8|962|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWU: TUVS INFILTRATES LUNG.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-353|8|963|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-354|8|963|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ lumbar spinal region infiltrating spine.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-355|8|965|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-356|8|965|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-357|8|966|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-358|8|966|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAC/  Carcinoma,MPATH: 218 - neoplasm|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-359|8|968|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-360|8|968|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-361|8|968|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-362|8|968|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-363|8|968|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-364|8|968|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-365|8|968|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-366|8|969|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-367|8|969|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-368|8|969|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-369|8|970|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-370|8|970|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-371|8|970|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-372|8|970|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-373|8|970|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-374|8|970|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-375|8|971|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-376|8|972|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-377|8|972|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-378|8|974|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-379|8|974|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-380|8|975|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-381|8|975|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-382|8|975|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-383|8|976|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF SKEL. MUSCLE.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-384|8|976|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ peritoneal tissue around left kidney.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-385|8|978|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-386|8|978|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-387|8|978|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-388|8|978|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-389|8|981|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-390|8|982|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-391|8|983|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-392|8|984|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-393|8|987|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-394|8|987|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWO: TOAC TO VISC PERIT.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-395|8|987|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-396|8|992|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSL/  undifferentiated leukemia lymphoret.tissue,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-397|8|992|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-398|8|992|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS INFILTRATES SKELETAL MUSC.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-399|8|994|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-400|8|994|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-401|8|995|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-402|8|995|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-403|8|996|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-404|8|996|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-405|8|996|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-406|8|997|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-407|8|1001|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-408|8|1001|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-409|8|1002|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-410|8|1002|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-411|8|1002|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-412|8|1003|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-413|8|1003|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-414|8|1003|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-415|8|1004|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-416|8|1005|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-417|8|1005|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-418|8|1006|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-419|8|1007|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-420|8|1007|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-421|8|1009|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-422|8|1009|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-423|8|1010|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-424|8|1010|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-425|8|1010|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-426|8|1012|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-427|8|1013|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-428|8|1013|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-429|8|1015|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-430|8|1015|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-431|8|1017|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-432|8|1017|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-433|8|1018|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-434|8|1018|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-435|8|1019|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-436|8|1019|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-437|8|1020|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-438|8|1022|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-439|8|1022|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-440|8|1023|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ lower abd. region.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-441|8|1023|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-442|8|1024|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-443|8|1025|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-444|8|1025|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-445|8|1025|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-446|8|1026|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-447|8|1027|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-448|8|1028|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-449|8|1029|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-450|8|1030|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-451|8|1030|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-452|8|1030|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-453|8|1030|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-454|8|1031|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-455|8|1032|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAC/ with metastasis through abd. wall to visc. peritoneum of spleen, kidney, & pancreas and to pancreas.,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-456|8|1033|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-457|8|1033|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-458|8|1033|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-459|8|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-460|8|1036|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-461|8|1036|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-462|8|1036|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-463|8|1036|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-464|8|1036|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-465|8|1037|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-466|8|1037|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-467|8|1038|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-468|8|1038|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-469|8|1039|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-470|8|1039|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-471|8|1039|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-472|8|1039|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-473|8|1041|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal,MPATH: 218 - neoplasm|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-474|8|1041|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-475|8|1043|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-476|8|1044|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ right upper abdominal region. Metastases  Muscle tcfs invas. of skel. muscle. Metastases  tcfs to visc. perit. of spleen, panc. & liver & visc. pleura (heart base). Metastases Lung,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-477|8|1044|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-478|8|1045|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-479|8|1046|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-480|8|1046|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/ alveolar and bronchiolar.,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-481|8|1047|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-482|8|1049|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-483|8|1049|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-484|8|1049|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal Metastases  Muscle tmab infiltration of muscle & dermis. Metastases Lung tmab metast. to lung.,MPATH: 218 - neoplasm|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-485|8|1051|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-486|8|1054|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-487|8|1055|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-488|8|1056|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-489|8|1058|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-490|8|1058|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-491|8|1058|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-492|8|1059|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-493|8|1059|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-494|8|1059|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-495|8|1061|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/   Metastases  Muscle tcfs infiltr. muscle & skin.,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-496|8|1061|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-497|8|1063|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-498|8|1063|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-499|8|1064|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-500|8|1064|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-501|8|1064|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-502|8|1065|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-503|8|1066|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-504|8|1066|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-505|8|1067|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-506|8|1067|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-507|8|1068|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-508|8|1069|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-509|8|1070|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-510|8|1070|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-511|8|1071|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-512|8|1072|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-513|8|1072|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. right thorax against ribs & extending dorsal. Metastases  Muscle tcfs infiltr. costal muscles. Metastases  tcfs infiltr. pleura of esoph.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-514|8|1072|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-515|8|1072|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-516|8|1073|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-517|8|1073|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-518|8|1074|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-519|8|1075|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-520|8|1075|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-521|8|1075|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-522|8|1077|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-523|8|1078|Other deterministic changes|Whole body|MCDU/   Metastases  trac to mediastinal tissue.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-524|8|1078|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-525|8|1079|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-526|8|1079|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-527|8|1079|Other deterministic changes|Lower respiratory system|MPNC/  Lung congestion|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-528|8|1081|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-529|8|1081|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Eye(s) missing Head/neck missing Thorax missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-530|8|1082|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-531|8|1082|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-532|8|1082|Neoplasia unclassified|Other local manifestations and miscellaneus|TSWC: TCVS INFILT. OF SKIN.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-533|8|1083|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-534|8|1083|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-535|8|1083|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-536|8|1086|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-537|8|1086|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-538|8|1088|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-539|8|1089|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-540|8|1089|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-541|8|1090|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-542|8|1090|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-543|8|1092|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung Metastases  Lymphoret.System tgac to pt ln & numerous other lymph nodules.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-544|8|1092|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-545|8|1092|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-546|8|1093|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-547|8|1093|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-548|8|1093|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-549|8|1093|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-550|8|1094|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-551|8|1094|Neoplasia systemic|Haematolymphatic system|TLPS/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-552|8|1095|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-553|8|1098|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-554|8|1099|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-555|8|1100|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-556|8|1101|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-557|8|1102|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-558|8|1102|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-559|8|1103|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-560|8|1103|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-561|8|1104|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ left inguinal region. Metastases  Skin tcvs infilt. of skin.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-562|8|1105|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-563|8|1106|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-564|8|1107|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-565|8|1110|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-566|8|1111|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-567|8|1112|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-568|8|1113|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-569|8|1114|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-570|8|1114|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-571|8|1114|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-572|8|1114|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-573|8|1115|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-574|8|1115|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-575|8|1117|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ left neck region. Metastases  Muscle tcfs infilt. of muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-576|8|1117|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-577|8|1120|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Skin tcfs infiltr. of skin.,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-578|8|1121|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ in fatty tissue dorsal subcut. lumbar region.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-579|8|1121|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-580|8|1123|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-581|8|1124|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-582|8|1125|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-583|8|1125|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-584|8|1127|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-585|8|1127|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-586|8|1127|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-587|8|1127|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-588|8|1128|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-589|8|1128|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-590|8|1129|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-591|8|1130|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-592|8|1130|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-593|8|1131|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-594|8|1132|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-595|8|1132|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-596|8|1134|Neoplasia systemic|Haematolymphatic system|TLPS/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-597|8|1137|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-598|8|1138|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-599|8|1139|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-600|8|1139|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-601|8|1140|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-602|8|1140|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-603|8|1142|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-604|8|1142|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-605|8|1142|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. left axillary region.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-606|8|1143|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-607|8|1144|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-608|8|1145|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-609|8|1145|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-610|8|1145|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-611|8|1147|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-612|8|1149|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWS: TSEC METAST. TO CN LN.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-613|8|1149|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-614|8|1149|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-615|8|1149|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-616|8|1150|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-617|8|1151|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-618|8|1152|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-619|8|1152|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-620|8|1154|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-621|8|1157|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-622|8|1158|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-623|8|1159|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-624|8|1159|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-625|8|1160|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-626|8|1160|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-627|8|1160|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-628|8|1163|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-629|8|1164|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-630|8|1165|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-631|8|1170|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-632|8|1171|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-633|8|1172|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-634|8|1175|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-635|8|1175|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-636|8|1176|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-637|8|1177|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-638|8|1177|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-639|8|1178|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-640|8|1178|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-641|8|1180|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-642|8|1180|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-643|8|1181|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-644|8|1182|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-645|8|1184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-646|8|1185|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-647|8|1187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-648|8|1187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-649|8|1188|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-650|8|1188|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|TSEC/ skin over salivary gland-neck. Metastases Lung Metastases  Lymphoret.System tsec metast. to cn ln.,MPATH: 218 - neoplasm|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-651|8|1189|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWR: TRAC EXTENSION INTO PLEURA & MEDIASTINUM.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-652|8|1190|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-653|8|1191|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-654|8|1191|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ interabd. lower belly region.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-655|8|1191|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-656|8|1191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-657|8|1193|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-658|8|1193|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-659|8|1196|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-660|8|1196|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-661|8|1199|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-662|8|1199|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-663|8|1199|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-664|8|1200|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-665|8|1202|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Muscle tcfs invades muscle.,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-666|8|1206|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. neck-over salivary gland. Metastases Lung Metastases  tcfs infiltr. sal. gland. Metastases  Muscle tcfs infilt. adjacent skeletal muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-667|8|1207|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-668|8|1207|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-669|8|1208|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-670|8|1209|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-671|8|1211|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-672|8|1212|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-673|8|1212|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-674|8|1217|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-675|8|1222|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-676|8|1222|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-677|8|1222|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-678|8|1223|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-679|8|1224|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-680|8|1227|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-681|8|1228|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-682|8|1229|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-683|8|1229|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-684|8|1232|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-685|8|1233|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-686|8|1235|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-687|8|1235|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-688|8|1237|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-689|8|1242|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-690|8|1245|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MMTA/  Metritis|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-691|8|1246|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-692|8|1246|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-693|8|1248|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-694|8|1249|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-695|8|1250|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-696|8|1252|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-697|8|1252|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-698|8|1255|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-699|8|1255|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-700|8|1257|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-701|8|1258|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-702|8|1262|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-703|8|1264|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-704|8|1267|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-705|8|1267|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-706|8|1268|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-707|8|1275|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-708|8|1276|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-709|8|1276|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-710|8|1277|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-711|8|1277|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-712|8|1278|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-713|8|1280|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-714|8|1282|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-715|8|1286|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-716|8|1287|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-717|8|1290|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-718|8|1291|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-719|8|1292|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-720|8|1294|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-721|8|1294|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-722|8|1295|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-723|8|1297|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-724|8|1298|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-725|8|1299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-726|8|1299|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-727|8|1300|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-728|8|1305|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ left thigh.|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-729|8|1311|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-730|8|1313|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-731|8|1316|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-732|8|1325|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-733|8|1327|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-734|8|1328|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-735|8|1331|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-736|8|1333|Other deterministic changes|Whole body|MCDU/|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-737|8|1336|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-738|8|1340|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. right dorsal lumbar region.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-739|8|1345|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-740|8|1347|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-741|8|1347|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-742|8|1348|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-743|8|1349|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-744|8|1374|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-745|8|1377|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-746|8|1405|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-747|8|1422|n/a|n/a|n/a|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-748|8|1445|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-749|8|1452|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases  Muscle tsec invas. of muscle.,MPATH: 513 - Lymphoid neoplasms|
1003-26-8|n/a,XC|1|100|shamexposed|0|milli grays|External exposure|code XC 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|739 records survival 866 ± 7 lifespan study|1003-26-8-750|8|1517|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-1|9|310|Neoplasia malignant|Bloodvessels among cardiovascular system|TLVS/ thymus. Lymphoret.tissue|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-2|9|317|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-3|9|348|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-4|9|351|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-5|9|408|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-6|9|442|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-7|9|460|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-8|9|475|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-9|9|487|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-10|9|506|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-11|9|533|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-12|9|544|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-13|9|554|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-14|9|563|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-15|9|564|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS INVADES MUSCLE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-16|9|570|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-17|9|580|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-18|9|582|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-19|9|583|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-20|9|601|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-21|9|602|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-22|9|603|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  Head/neck missing,MPATH: 242 - hemangiosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-23|9|621|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-24|9|623|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-25|9|646|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-26|9|651|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-27|9|653|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-28|9|659|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-29|9|661|Neoplasia benign|Ovary among reproductive system diseases|TOTO/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-30|9|664|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-31|9|666|Neoplasia malignant|Other local manifestations and miscellaneus|TCSS/ TCSS/ TCSS/ TCSS/ pelvic area. Metastases  Muscle tcss of pelvic area to diaphragm. Metastases Lung|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-32|9|668|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-33|9|670|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-34|9|675|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-35|9|677|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-36|9|679|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-37|9|680|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-38|9|683|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-39|9|688|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-40|9|698|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-41|9|698|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-42|9|703|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-43|9|704|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-44|9|704|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-45|9|708|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-46|9|708|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-47|9|710|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-48|9|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-49|9|715|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-50|9|719|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-51|9|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-52|9|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-53|9|730|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-54|9|732|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-55|9|736|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-56|9|739|Neoplasia malignant|Bloodvessels among cardiovascular system|TBVS/ ribs & spine in thor. reg.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-57|9|740|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-58|9|741|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-59|9|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-60|9|744|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-61|9|744|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-62|9|744|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-63|9|744|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-64|9|745|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-65|9|747|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-66|9|750|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-67|9|751|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-68|9|751|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/ with metastasis to liver.,MPATH: 242 - hemangiosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-69|9|753|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-70|9|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSL/  undifferentiated leukemia lymphoret.tissue,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-71|9|757|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-72|9|758|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-73|9|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-74|9|765|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-75|9|770|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-76|9|773|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-77|9|776|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-78|9|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-79|9|778|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-80|9|779|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-81|9|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-82|9|782|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-83|9|783|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-84|9|784|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-85|9|784|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-86|9|791|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-87|9|791|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-88|9|791|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-89|9|792|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-90|9|794|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-91|9|794|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-92|9|794|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to intercostal.,MPATH: 268 - adenocarcinoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-93|9|795|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-94|9|798|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-95|9|801|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-96|9|802|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-97|9|804|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-98|9|806|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-99|9|806|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-100|9|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-101|9|806|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-102|9|808|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-103|9|809|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-104|9|812|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-105|9|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-106|9|818|Neoplasia unclassified|Other local manifestations and miscellaneus|TSWC: TCFS INFILT. SKIN ON BELLY.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-107|9|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases  Muscle tcss to muscle, mammary gland & bone.,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-108|9|820|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-109|9|821|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-110|9|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-111|9|823|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-112|9|824|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-113|9|824|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF MUSCLE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-114|9|824|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF MUSCLE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-115|9|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-116|9|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-117|9|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-118|9|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-119|9|833|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-120|9|834|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-121|9|834|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-122|9|837|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-123|9|837|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-124|9|840|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-125|9|840|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-126|9|841|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-127|9|842|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-128|9|842|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-129|9|843|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-130|9|844|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-131|9|844|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF MUSCLE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-132|9|848|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-133|9|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-134|9|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-135|9|852|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCSS TO MUSCLE, MAMMARY GLAND & BONE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-136|9|852|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-137|9|854|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-138|9|855|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-139|9|855|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-140|9|857|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-141|9|861|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-142|9|861|Neoplasia unclassified|Other local manifestations and miscellaneus|TSWC: TCFS INFILT. SKIN ON BELLY.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-143|9|862|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-144|9|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-145|9|863|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-146|9|863|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-147|9|863|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-148|9|869|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-149|9|870|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF ADJACENT MUSCLE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-150|9|870|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-151|9|871|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-152|9|873|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-153|9|874|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-154|9|874|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-155|9|876|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-156|9|876|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-157|9|876|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-158|9|878|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-159|9|881|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-160|9|882|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-161|9|883|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-162|9|884|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-163|9|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-164|9|885|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-165|9|887|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-166|9|890|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  tcss of pelvic area to perit-- soft tiss.,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-167|9|891|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-168|9|894|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-169|9|894|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-170|9|894|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-171|9|894|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-172|9|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-173|9|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-174|9|895|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-175|9|895|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-176|9|896|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-177|9|897|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-178|9|897|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-179|9|898|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-180|9|898|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-181|9|899|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-182|9|900|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal Metastases  trac metast to pleura & mediastinum.,MPATH: 218 - neoplasm|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-183|9|903|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-184|9|903|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-185|9|904|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCSS TO MUSCLE, MAMMARY GLAND & BONE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-186|9|905|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ with leukemia.,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-187|9|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases  Muscle tmab invas. of underlying muscle.,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-188|9|909|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-189|9|910|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-190|9|910|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ lt forelimb.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-191|9|910|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCSS TO MUSCLE, MAMMARY GLAND & BONE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-192|9|911|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF SKEL. MUSCLE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-193|9|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-194|9|911|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-195|9|912|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-196|9|912|Inflammation and/or fibrotic diseases|Lower digestive tract,MA: 0000328 - intestine|MIIA/ colon.Enteritis acute,MPATH: 212 - inflammation|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-197|9|913|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-198|9|915|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-199|9|916|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-200|9|917|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-201|9|922|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-202|9|922|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-203|9|924|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-204|9|924|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-205|9|925|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-206|9|925|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-207|9|926|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-208|9|927|Inflammation and/or fibrotic diseases|Lower digestive tract,MA: 0000328 - intestine|MIIA/ ileum.Enteritis acute,MPATH: 212 - inflammation|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-209|9|929|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-210|9|929|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-211|9|930|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-212|9|931|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-213|9|931|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-214|9|932|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-215|9|934|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-216|9|935|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-217|9|935|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ left axillary region. Metastases Lung Metastases  Lymphoret.System tcfs to cervical node. Metastases  tcfs to soft tissue to base of heart & mediastinal region.Eye(s) missing Head/neck missing,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-218|9|936|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-219|9|936|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-220|9|937|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-221|9|939|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-222|9|941|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-223|9|942|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-224|9|943|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-225|9|946|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-226|9|946|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-227|9|947|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-228|9|948|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-229|9|948|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF SKELETAL MUSCLE & BONE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-230|9|951|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-231|9|951|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-232|9|952|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-233|9|953|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-234|9|954|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-235|9|955|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-236|9|956|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-237|9|956|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-238|9|956|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-239|9|960|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-240|9|960|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-241|9|961|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-242|9|967|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-243|9|967|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-244|9|968|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-245|9|969|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-246|9|969|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-247|9|970|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-248|9|970|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-249|9|971|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-250|9|971|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-251|9|974|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-252|9|975|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-253|9|975|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-254|9|975|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-255|9|975|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-256|9|976|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-257|9|976|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWM: TMAB INVAS. OF UNDERLYING MUSCLE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-258|9|976|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-259|9|978|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-260|9|978|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-261|9|978|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-262|9|979|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-263|9|979|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-264|9|980|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-265|9|980|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-266|9|981|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF SKELETAL MUSCLE & BONE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-267|9|982|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-268|9|983|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-269|9|985|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-270|9|986|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-271|9|988|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-272|9|990|Neoplasia malignant|Other local manifestations and miscellaneus|TCSS/ TCSS/ TCSS/ TCSS/ right axillary reg. & surround humerus.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-273|9|991|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-274|9|992|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-275|9|992|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-276|9|993|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-277|9|994|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-278|9|995|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-279|9|996|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-280|9|997|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-281|9|997|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-282|9|999|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-283|9|999|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-284|9|1001|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-285|9|1002|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-286|9|1003|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-287|9|1003|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-288|9|1003|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-289|9|1003|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-290|9|1003|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-291|9|1007|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF ADJACENT MUSCLE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-292|9|1008|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF SKEL. MUSCLE.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-293|9|1009|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-294|9|1010|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-295|9|1011|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-296|9|1011|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-297|9|1011|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-298|9|1012|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-299|9|1013|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-300|9|1013|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-301|9|1013|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-302|9|1015|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-303|9|1015|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-304|9|1015|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-305|9|1016|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-306|9|1018|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lumbar spine. Metastases  Muscle tbos invades muscle. Metastases Lung|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-307|9|1020|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-308|9|1020|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-309|9|1026|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-310|9|1026|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-311|9|1027|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-312|9|1027|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-313|9|1028|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-314|9|1028|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-315|9|1029|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-316|9|1029|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCSS OF PELVIC AREA TO DIAPHRAGM.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-317|9|1030|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-318|9|1031|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-319|9|1032|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-320|9|1032|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-321|9|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-322|9|1037|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-323|9|1037|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-324|9|1039|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-325|9|1040|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-326|9|1040|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MPNI/  acute/chronic,MPATH: 212 - inflammation|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-327|9|1041|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-328|9|1042|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-329|9|1043|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-330|9|1044|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-331|9|1045|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-332|9|1046|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-333|9|1048|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-334|9|1048|Neoplasia unclassified|Other local manifestations and miscellaneus|TSWC: TCVS OF THIGH INFILTR. SKIN.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-335|9|1049|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-336|9|1050|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-337|9|1051|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-338|9|1051|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-339|9|1055|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-340|9|1056|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-341|9|1056|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-342|9|1058|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-343|9|1058|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-344|9|1058|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-345|9|1058|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-346|9|1059|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-347|9|1059|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-348|9|1060|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-349|9|1062|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-350|9|1062|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-351|9|1065|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-352|9|1065|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-353|9|1065|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-354|9|1068|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-355|9|1069|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-356|9|1070|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-357|9|1070|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-358|9|1073|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-359|9|1074|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-360|9|1075|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-361|9|1075|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-362|9|1078|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-363|9|1079|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-364|9|1080|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-365|9|1080|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-366|9|1083|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-367|9|1086|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-368|9|1092|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-369|9|1092|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-370|9|1093|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-371|9|1093|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. on belly. Metastases  Skin tcfs infilt. skin on belly.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-372|9|1096|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-373|9|1097|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-374|9|1098|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-375|9|1099|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-376|9|1100|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-377|9|1100|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-378|9|1101|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-379|9|1102|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-380|9|1107|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-381|9|1108|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-382|9|1108|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-383|9|1108|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-384|9|1108|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-385|9|1109|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-386|9|1109|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-387|9|1112|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-388|9|1112|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-389|9|1114|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-390|9|1114|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-391|9|1114|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-392|9|1114|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-393|9|1116|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-394|9|1116|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Head/neck missing,MPATH: 268 - adenocarcinoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-395|9|1117|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-396|9|1118|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-397|9|1119|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-398|9|1121|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-399|9|1122|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-400|9|1123|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. dorsal-across shoulders. Metastases  Muscle tcfs invas. of adjacent muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-401|9|1123|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-402|9|1125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-403|9|1126|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. & interabdom. lower rt. quadrant. Metastases  Muscle tcfs invas. of skeletal muscle & bone.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-404|9|1127|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCSS OF PELVIC AREA TO DIAPHRAGM.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-405|9|1127|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-406|9|1128|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-407|9|1128|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-408|9|1128|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-409|9|1129|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-410|9|1130|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-411|9|1130|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-412|9|1131|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-413|9|1133|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-414|9|1134|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-415|9|1135|Neoplasia malignant|Adrenal gland  among endocrine systems|TAPS/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-416|9|1135|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-417|9|1141|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-418|9|1141|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-419|9|1142|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-420|9|1142|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-421|9|1144|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-422|9|1145|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-423|9|1145|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-424|9|1148|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-425|9|1151|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ 2 sites - subcut. right axillary & femoral regions. Metastases  Muscle tcfs infiltr. muscle. Metastases Lung Metastases  Skin tcfs infiltr. skin.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-426|9|1156|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-427|9|1157|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-428|9|1159|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-429|9|1160|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-430|9|1162|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-431|9|1164|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-432|9|1164|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-433|9|1165|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-434|9|1166|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-435|9|1167|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-436|9|1167|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-437|9|1170|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-438|9|1172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-439|9|1172|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-440|9|1174|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-441|9|1174|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-442|9|1177|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-443|9|1177|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-444|9|1179|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing Thorax missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-445|9|1185|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-446|9|1188|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-447|9|1188|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-448|9|1192|Other deterministic changes|Whole body|MCDU/  Head/neck missing|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-449|9|1193|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-450|9|1194|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ left thigh. Metastases  Skin tcvs of thigh infiltr. skin.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-451|9|1201|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-452|9|1206|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-453|9|1209|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-454|9|1210|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-455|9|1214|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-456|9|1214|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ in the peritoneal cavity-near left kidney. Metastases  Muscle tcfs invas. of muscle. Metastases  tcfs spread to peritoneum.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-457|9|1216|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-458|9|1216|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-459|9|1220|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-460|9|1221|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ muscle wall of sm. intest.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-461|9|1223|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-462|9|1226|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-463|9|1228|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-464|9|1236|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-465|9|1237|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-466|9|1238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-467|9|1244|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-468|9|1245|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ right hind leg-subcut. Metastases  Muscle tcfs invas. of skel. muscle. Metastases  tcfs invas. of visc. perit. kidney. caps.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-469|9|1248|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ on back subcut. left lumbar region.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-470|9|1254|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-471|9|1270|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-472|9|1272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-473|9|1275|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-474|9|1279|Neoplasia malignant|Other local manifestations and miscellaneus|TMSS/ TMSS/ TMSS/ TMSS/ left thigh.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-475|9|1280|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-476|9|1290|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-477|9|1294|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-478|9|1297|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-479|9|1299|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-480|9|1310|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-481|9|1311|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-482|9|1312|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-483|9|1314|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-484|9|1322|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-485|9|1323|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-486|9|1325|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-487|9|1326|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-488|9|1332|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-489|9|1335|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-490|9|1353|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-491|9|1355|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-492|9|1360|Neoplasia malignant|Adrenal gland  among endocrine systems|TAPS/ with liver or lung metast.-no identifying normal tissue.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-493|9|1366|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCSS OF PELVIC AREA TO DIAPHRAGM.|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-494|9|1369|Neoplasia malignant|Adrenal gland  among endocrine systems|TAPS/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-495|9|1375|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-496|9|1378|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-497|9|1387|Other deterministic changes|Whole body|MCDU/|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-498|9|1389|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-499|9|1444|n/a|n/a|n/a|
1003-26-9|n/a,X1|1|100|gamma-rays Co-60|0.225|grays|External exposure|code X1 1 fraction 20 m|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|497 records survival 844 ± 9 lifespan study|1003-26-9-500|9|1450|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-1|10|330|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-2|10|350|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-3|10|350|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-4|10|350|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-5|10|407|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-6|10|414|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSL/  undifferentiated leukemia lymphoret.tissue,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-7|10|425|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-8|10|484|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-9|10|534|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-10|10|548|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-11|10|550|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ myoepithelioma of saliv gl.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-12|10|552|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-13|10|578|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-14|10|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-15|10|590|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-16|10|598|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-17|10|599|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-18|10|600|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-19|10|601|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-20|10|608|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-21|10|610|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-22|10|618|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-23|10|622|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-24|10|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-25|10|647|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-26|10|650|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-27|10|652|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-28|10|660|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-29|10|666|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-30|10|678|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-31|10|679|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-32|10|679|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-33|10|681|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-34|10|682|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSS/  undifferentiated lymphoma,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-35|10|686|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS TO SKELETAL MUSCLE.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-36|10|687|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-37|10|695|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-38|10|697|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-39|10|698|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-40|10|699|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-41|10|702|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWK: TKAC TO AXILLARY MUSCLE.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-42|10|712|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-43|10|715|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-44|10|718|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lumbar & sacral spine.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-45|10|724|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-46|10|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-47|10|728|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-48|10|729|Other deterministic changes|Whole body|MCDU/|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-49|10|731|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-50|10|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-51|10|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-52|10|742|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-53|10|743|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOAC/  ,MPATH: 218 - neoplasm|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-54|10|745|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ musc surrounding femur. Muscle|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-55|10|745|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-56|10|746|Other deterministic changes|Whole body|MCDU/|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-57|10|749|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-58|10|750|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-59|10|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-60|10|759|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-61|10|763|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-62|10|765|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-63|10|771|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-64|10|771|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-65|10|772|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-66|10|773|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-67|10|778|Other deterministic changes|Whole body|MCDU/|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-68|10|787|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-69|10|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-70|10|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-71|10|802|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-72|10|803|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-73|10|811|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-74|10|812|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-75|10|813|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-76|10|813|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-77|10|816|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-78|10|821|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-79|10|823|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-80|10|824|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-81|10|827|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-82|10|828|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-83|10|829|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-84|10|830|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-85|10|836|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-86|10|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-87|10|838|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-88|10|839|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-89|10|839|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-90|10|840|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-91|10|841|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-92|10|843|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-93|10|843|Other deterministic changes|Whole body|MCDU/|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-94|10|851|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/   Metastases Lung|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-95|10|852|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-96|10|854|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-97|10|860|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-98|10|865|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-99|10|868|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-100|10|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-101|10|872|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-102|10|873|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-103|10|876|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-104|10|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-105|10|879|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-106|10|879|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-107|10|883|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-108|10|883|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS TO SKELETAL MUSCLE.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-109|10|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-110|10|885|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-111|10|888|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-112|10|889|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-113|10|889|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-114|10|890|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-115|10|892|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-116|10|894|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-117|10|896|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-118|10|896|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-119|10|896|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-120|10|897|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-121|10|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-122|10|900|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-123|10|903|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-124|10|904|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-125|10|904|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-126|10|905|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-127|10|906|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|TDTC/  Transitional cell,MPATH: 549 - carcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-128|10|907|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-129|10|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-130|10|910|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-131|10|911|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-132|10|912|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-133|10|913|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-134|10|914|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-135|10|915|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-136|10|916|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-137|10|916|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-138|10|916|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-139|10|917|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-140|10|920|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-141|10|921|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-142|10|926|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-143|10|926|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-144|10|928|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-145|10|929|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-146|10|933|Neoplasia malignant|Other local manifestations and miscellaneus|TCSS/ TCSS/ TCSS/ TCSS/ rt thoracic lateral.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-147|10|934|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-148|10|935|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-149|10|935|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-150|10|936|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-151|10|939|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ in mesentery.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-152|10|940|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-153|10|941|Inflammation and/or fibrotic diseases|Lower digestive tract,MA: 0000328 - intestine|MIIA/ sm intestine.Enteritis acute,MPATH: 212 - inflammation|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-154|10|941|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TOAO/  AdenomaEye(s) missing Head/neck missing,MPATH: 418 - liposarcoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-155|10|944|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBFS OF RIBS INFILTR. MUSCLE.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-156|10|948|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-157|10|955|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-158|10|956|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-159|10|960|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-160|10|960|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-161|10|961|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-162|10|961|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-163|10|966|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-164|10|967|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-165|10|967|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-166|10|967|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ 2 sites-subcut. right axillary region & subcut. dorsal lumbar region. Metastases  Skin tcfs infiltr. of skin. Metastases  Muscle tcfs infiltr. of skeletal muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-167|10|968|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-168|10|968|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-169|10|971|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-170|10|972|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-171|10|975|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-172|10|978|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-173|10|979|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-174|10|981|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-175|10|982|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-176|10|985|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILTR. OF SKELETAL MUSCLE.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-177|10|988|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-178|10|988|Other deterministic changes|Whole body|MCDU/  Eye(s) missing Head/neck missing|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-179|10|989|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  Head/neck missing Thorax missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-180|10|991|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-181|10|991|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-182|10|991|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-183|10|991|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-184|10|994|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-185|10|994|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-186|10|995|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-187|10|996|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-188|10|997|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-189|10|998|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-190|10|1000|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ subcut on back w/ metastasis to spleen.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-191|10|1000|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-192|10|1001|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-193|10|1001|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-194|10|1002|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-195|10|1005|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-196|10|1006|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-197|10|1008|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-198|10|1011|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-199|10|1012|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-200|10|1015|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-201|10|1016|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-202|10|1016|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-203|10|1019|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-204|10|1020|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-205|10|1021|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung Metastases Heart Metastases  Muscle tkac to axillary muscle.,MPATH: 549 - carcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-206|10|1022|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-207|10|1022|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-208|10|1022|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-209|10|1023|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-210|10|1023|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-211|10|1024|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-212|10|1024|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-213|10|1032|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-214|10|1032|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-215|10|1033|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-216|10|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-217|10|1034|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-218|10|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-219|10|1035|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-220|10|1037|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-221|10|1037|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-222|10|1037|Other deterministic changes|Whole body|MCDU/|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-223|10|1037|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-224|10|1039|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-225|10|1040|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-226|10|1043|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-227|10|1043|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-228|10|1045|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lumbar spine. Metastases  Muscle tbos invas. of muscle of lower back. Metastases Lung|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-229|10|1045|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-230|10|1050|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-231|10|1051|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-232|10|1053|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-233|10|1053|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-234|10|1057|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-235|10|1058|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS TO SKELETAL MUSCLE.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-236|10|1058|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-237|10|1059|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-238|10|1059|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-239|10|1059|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Eye(s) missing Head/neck missing,MPATH: 268 - adenocarcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-240|10|1061|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-241|10|1063|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-242|10|1063|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-243|10|1065|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-244|10|1065|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-245|10|1065|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-246|10|1066|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-247|10|1067|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-248|10|1068|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-249|10|1069|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Thorax missing Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-250|10|1070|Other deterministic changes|Whole body|MCDU/|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-251|10|1070|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-252|10|1071|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-253|10|1074|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-254|10|1075|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-255|10|1076|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-256|10|1086|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-257|10|1088|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-258|10|1088|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-259|10|1090|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-260|10|1090|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-261|10|1092|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-262|10|1103|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-263|10|1103|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-264|10|1104|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-265|10|1104|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-266|10|1106|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-267|10|1107|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-268|10|1111|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-269|10|1114|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-270|10|1114|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-271|10|1119|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-272|10|1120|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-273|10|1121|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|TDTC/  Transitional cell,MPATH: 549 - carcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-274|10|1121|Neoplasia benign|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVO/  ,MPATH: 240 - hemangioma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-275|10|1121|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-276|10|1124|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-277|10|1124|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-278|10|1125|Other deterministic changes|Whole body|MCDU/  Head/neck missing|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-279|10|1128|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-280|10|1129|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-281|10|1131|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-282|10|1137|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-283|10|1137|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-284|10|1139|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-285|10|1142|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-286|10|1143|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-287|10|1145|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-288|10|1145|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-289|10|1158|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-290|10|1159|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-291|10|1161|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-292|10|1162|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ right thigh. Metastases  Muscle tcvs infilt. thigh muscle.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-293|10|1164|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-294|10|1165|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-295|10|1168|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-296|10|1169|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-297|10|1171|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-298|10|1171|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-299|10|1172|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-300|10|1174|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-301|10|1177|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-302|10|1190|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-303|10|1191|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-304|10|1193|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ subcut. left lateral region.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-305|10|1195|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-306|10|1198|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-307|10|1205|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-308|10|1205|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-309|10|1207|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-310|10|1209|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-311|10|1216|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-312|10|1218|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBFS OF RIBS INFILTR. MUSCLE.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-313|10|1218|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-314|10|1221|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-315|10|1223|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-316|10|1230|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-317|10|1235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-318|10|1238|Other deterministic changes|Whole body|MCDU/|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-319|10|1241|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-320|10|1243|Other deterministic changes|Whole body|MCDU/|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-321|10|1247|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-322|10|1249|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-323|10|1254|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-324|10|1255|Neoplasia malignant|Adrenal gland  among endocrine systems|TAPS/ bilateral.|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-325|10|1260|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-326|10|1263|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-327|10|1267|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-328|10|1269|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-329|10|1269|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-330|10|1273|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-331|10|1282|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-332|10|1286|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-333|10|1288|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-334|10|1296|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-335|10|1296|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-336|10|1301|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. right axillary region. Metastases  Muscle tcfs to skeletal muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-337|10|1301|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-338|10|1306|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-339|10|1307|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TIAC/ anal prolapse.,MPATH: 218 - neoplasm|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-340|10|1311|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-341|10|1330|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-342|10|1330|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-343|10|1335|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-344|10|1335|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-345|10|1359|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-346|10|1360|n/a|n/a|n/a|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-347|10|1404|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-348|10|1415|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|TBFS/ ribs. Metastases  Muscle tbfs of ribs infiltr. muscle.,MPATH: 551 - sarcoma|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-349|10|1418|Other deterministic changes|Whole body|MCDU/|
1003-26-10|n/a,X2|1|100|gamma-rays Co-60|0.45|grays|External exposure|code X2 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|346 records survival 850 ± 11 lifespan study|1003-26-10-350|10|1422|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-1|11|115|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-2|11|115|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-3|11|115|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-4|11|115|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-5|11|115|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-6|11|361|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-7|11|443|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-8|11|465|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-9|11|481|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF INGUINAL REG. INFILTR. MUSCLE & MAMMARY GLAND.|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-10|11|515|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-11|11|519|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-12|11|527|Inflammation and/or fibrotic diseases|Lower digestive tract,MA: 0000328 - intestine|MIIA/ caecum.Enteritis acute,MPATH: 212 - inflammation|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-13|11|532|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-14|11|540|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-15|11|551|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MPNU/  Acute and subacute,MPATH: 212 - inflammation|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-16|11|553|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-17|11|559|Other deterministic changes|Whole body|MCDU/|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-18|11|571|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-19|11|608|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-20|11|613|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-21|11|625|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-22|11|645|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-23|11|645|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-24|11|673|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-25|11|682|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-26|11|692|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-27|11|694|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-28|11|694|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-29|11|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-30|11|704|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-31|11|736|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MMTA/  Metritis|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-32|11|739|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-33|11|740|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-34|11|743|Other deterministic changes|Whole body|MCDU/|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-35|11|746|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-36|11|760|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-37|11|762|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ fibrohistiosarcoma-- perit-- invades spleen, adrenals, & pelvic kid region, soft tiss. Metastases Liver Metastases  Lymphoret.System txus invades mediastinal node.|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-38|11|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-39|11|769|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal,MPATH: 218 - neoplasm|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-40|11|773|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-41|11|774|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-42|11|775|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-43|11|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-44|11|781|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-45|11|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-46|11|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-47|11|799|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-48|11|802|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS INFILT. INTO MUSCLE.|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-49|11|805|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-50|11|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-51|11|814|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-52|11|819|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-53|11|821|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-54|11|824|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/ with spine fracture; probable bone meta-stasis, but not seen.Predominantly ductal,MPATH: 218 - neoplasm|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-55|11|826|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-56|11|828|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-57|11|829|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-58|11|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-59|11|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-60|11|833|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-61|11|838|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-62|11|839|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-63|11|841|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-64|11|843|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-65|11|844|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-66|11|848|Neoplasia malignant|Bloodvessels among cardiovascular system|TSVS/ on dorsal pelvis.Skin|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-67|11|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-68|11|854|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-69|11|861|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-70|11|865|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-71|11|868|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-72|11|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-73|11|870|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-74|11|870|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-75|11|870|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-76|11|874|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-77|11|874|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-78|11|881|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-79|11|883|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-80|11|883|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-81|11|884|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-82|11|885|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-83|11|892|Other deterministic changes|Whole body|MCDU/|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-84|11|893|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-85|11|893|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-86|11|895|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-87|11|898|Neoplasia unclassified|Other local manifestations and miscellaneus|THWX: TXUS INVADES LIVER.|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-88|11|899|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-89|11|905|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-90|11|906|Other deterministic changes|Whole body|MCDU/  Thorax missing|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-91|11|911|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-92|11|911|Other deterministic changes|Whole body|MCDU/|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-93|11|915|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-94|11|915|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-95|11|917|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-96|11|920|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ left axillary region.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-97|11|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-98|11|945|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-99|11|952|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-100|11|953|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-101|11|958|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-102|11|959|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-103|11|965|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-104|11|966|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-105|11|967|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-106|11|967|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-107|11|968|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  Head/neck missing Eye(s) missing|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-108|11|969|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|TZAC/  ,MPATH: 278 - follicular adenocarcinoma|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-109|11|973|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-110|11|973|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-111|11|974|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-112|11|976|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-113|11|976|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-114|11|985|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-115|11|991|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ subcut lt groin region. Metastases Lung|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-116|11|994|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-117|11|997|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-118|11|1003|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-119|11|1004|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-120|11|1009|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-121|11|1011|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-122|11|1011|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-123|11|1013|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-124|11|1018|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-125|11|1019|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-126|11|1020|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. and intraperiton. on right side three discrete masses. Metastases  Muscle tcfs invasion of muscle - subcut.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-127|11|1021|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. left inguinal region. Metastases  Muscle tcfs of inguinal reg. infiltr. muscle & mammary gland.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-128|11|1030|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-129|11|1030|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-130|11|1031|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-131|11|1034|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-132|11|1035|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-133|11|1036|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-134|11|1037|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-135|11|1038|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-136|11|1039|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-137|11|1039|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-138|11|1042|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-139|11|1042|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-140|11|1045|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-141|11|1047|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-142|11|1048|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-143|11|1051|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-144|11|1051|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-145|11|1052|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-146|11|1054|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-147|11|1056|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-148|11|1058|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-149|11|1058|Neoplasia unclassified|Other local manifestations and miscellaneus|THWX: TXUS INVADES LIVER.|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-150|11|1058|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-151|11|1058|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-152|11|1063|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-153|11|1066|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-154|11|1068|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-155|11|1068|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-156|11|1072|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|TNMS/   Metastases  Muscle tcvs infilt. into muscle.,MPATH: 551 - sarcoma|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-157|11|1077|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-158|11|1081|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-159|11|1085|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-160|11|1086|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-161|11|1090|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-162|11|1091|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-163|11|1094|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-164|11|1105|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-165|11|1106|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-166|11|1114|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-167|11|1115|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-168|11|1118|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-169|11|1121|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-170|11|1121|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-171|11|1122|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-172|11|1128|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-173|11|1129|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-174|11|1139|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-175|11|1142|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-176|11|1147|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-177|11|1162|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-178|11|1171|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-179|11|1177|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-180|11|1179|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-181|11|1183|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVASION OF MUSCLE - SUBCUT.|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-182|11|1183|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-183|11|1186|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-184|11|1189|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-185|11|1192|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-186|11|1192|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-187|11|1199|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-188|11|1201|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-189|11|1211|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-190|11|1213|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-191|11|1222|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-192|11|1230|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWC: TCVS OF GROIN TO LUNG.|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-193|11|1242|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-194|11|1250|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-195|11|1286|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-196|11|1291|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-197|11|1307|n/a|n/a|n/a|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-198|11|1334|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-199|11|1341|Other deterministic changes|Whole body|MCDU/|
1003-26-11|n/a,X3|1|100|gamma-rays Co-60|0.9|grays|External exposure|code X3 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|194 records survival 819 ± 14 lifespan study|1003-26-11-200|11|1398|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-1|12|115|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-2|12|115|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-3|12|115|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-4|12|115|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-5|12|115|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-6|12|127|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-7|12|127|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-8|12|127|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-9|12|211|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-10|12|253|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-11|12|316|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-12|12|324|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-13|12|347|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-14|12|395|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-15|12|414|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-16|12|450|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-17|12|494|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-18|12|509|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-19|12|514|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-20|12|520|Inflammation and/or fibrotic diseases|Lower digestive tract,MA: 0000328 - intestine|MIIA/ jejunum.Enteritis acute,MPATH: 212 - inflammation|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-21|12|521|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-22|12|523|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-23|12|524|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-24|12|541|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-25|12|554|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-26|12|561|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-27|12|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-28|12|562|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-29|12|578|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-30|12|583|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-31|12|589|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|TDTC/  Transitional cell,MPATH: 549 - carcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-32|12|592|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-33|12|594|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-34|12|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSL/  undifferentiated leukemia lymphoret.tissue,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-35|12|596|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-36|12|596|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-37|12|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-38|12|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-39|12|609|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-40|12|612|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-41|12|617|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-42|12|617|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-43|12|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-44|12|624|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-45|12|639|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testisHead/neck missing,MPATH: 62 - cyst|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-46|12|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-47|12|641|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-48|12|646|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-49|12|649|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal,MPATH: 218 - neoplasm|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-50|12|662|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-51|12|662|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-52|12|666|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-53|12|666|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-54|12|666|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-55|12|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-56|12|672|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-57|12|674|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-58|12|675|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-59|12|676|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-60|12|678|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-61|12|683|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-62|12|683|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-63|12|683|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-64|12|683|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-65|12|683|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-66|12|683|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-67|12|690|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-68|12|694|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-69|12|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-70|12|696|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-71|12|697|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-72|12|698|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-73|12|700|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-74|12|701|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-75|12|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-76|12|702|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-77|12|705|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-78|12|710|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-79|12|711|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-80|12|712|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-81|12|715|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-82|12|717|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-83|12|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-84|12|718|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-85|12|722|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-86|12|722|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-87|12|723|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWH: THAC TO PERITONEAL SURFACE OF KIDNEY.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-88|12|724|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-89|12|727|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-90|12|728|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-91|12|729|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-92|12|731|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|TMRS/ dorsal subcut in rt lumbar region. Metastases  tmrs invades diaphragm & perit.,MPATH: 428 - rhabdomyosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-93|12|733|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-94|12|738|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-95|12|743|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-96|12|743|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-97|12|743|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-98|12|745|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-99|12|745|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-100|12|745|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-101|12|746|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-102|12|747|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-103|12|749|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-104|12|750|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-105|12|751|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-106|12|751|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-107|12|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-108|12|753|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-109|12|753|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-110|12|756|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-111|12|757|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-112|12|757|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-113|12|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-114|12|758|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-115|12|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-116|12|761|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-117|12|761|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-118|12|762|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-119|12|763|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-120|12|764|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-121|12|764|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-122|12|765|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-123|12|765|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MMTA/  Metritis|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-124|12|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-125|12|767|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-126|12|767|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-127|12|769|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-128|12|769|Neoplasia malignant|Bloodvessels among cardiovascular system|TSVS/ dorsal thigh.Skin Metastases  Muscle tsvs infiltr thigh musc.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-129|12|769|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-130|12|770|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-131|12|770|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-132|12|771|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-133|12|772|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-134|12|774|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-135|12|776|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-136|12|778|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-137|12|779|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-138|12|780|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-139|12|782|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-140|12|782|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-141|12|783|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-142|12|785|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-143|12|786|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-144|12|786|Neoplasia systemic|Haematolymphatic system|TLPS/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-145|12|786|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-146|12|787|Other deterministic changes|Whole body|MCDU/   Metastases Liver|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-147|12|792|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-148|12|792|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-149|12|792|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-150|12|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-151|12|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-152|12|793|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-153|12|794|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-154|12|794|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-155|12|794|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-156|12|795|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-157|12|795|Neoplasia malignant|Endocrine system|TGAC/ w/ eye involvement. Metastases  tgac to brain.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-158|12|796|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-159|12|797|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWU: TUEC TO LUNG.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-160|12|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-161|12|798|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|MTHR/  auricular|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-162|12|798|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-163|12|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-164|12|800|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-165|12|801|Neoplasia unclassified|Other local manifestations and miscellaneus|TSWC: TCFS INFILT. OF SKIN.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-166|12|802|Neoplasia systemic|Haematolymphatic system|TLPS/  Head/neck missing|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-167|12|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-168|12|803|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-169|12|803|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-170|12|804|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-171|12|806|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-172|12|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-173|12|811|Neoplasia systemic|Haematolymphatic system|TLPS/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-174|12|812|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|TIEC/ stomach.,MPATH: 549 - carcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-175|12|813|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-176|12|815|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-177|12|815|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-178|12|817|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-179|12|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-180|12|820|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-181|12|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-182|12|823|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-183|12|824|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|TNNS/ back. Metastases Skin tnns to skin of back. Metastases  Muscle tnns to skeletal musc of back.,MPATH: 437 - neurofibrosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-184|12|824|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-185|12|825|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-186|12|825|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-187|12|826|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-188|12|826|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-189|12|827|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-190|12|834|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-191|12|834|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-192|12|834|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal Metastases Lung,MPATH: 218 - neoplasm|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-193|12|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases  Skin tcfs infiltr. of skin with ulceration.,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-194|12|835|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-195|12|835|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-196|12|836|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-197|12|838|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-198|12|838|Neoplasia unclassified|Other local manifestations and miscellaneus|TNWB: TBOS OF LUMBAR SPINE INFILTRATES SPINAL CORD.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-199|12|839|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-200|12|841|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-201|12|841|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-202|12|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-203|12|846|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-204|12|849|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-205|12|850|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-206|12|850|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-207|12|851|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWG: TGAC INFILT. EYEBALL.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-208|12|855|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-209|12|857|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-210|12|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-211|12|863|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-212|12|863|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-213|12|864|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-214|12|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-215|12|866|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXUO/ thymoma, epithelial type.,MPATH: 218 - neoplasm|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-216|12|867|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-217|12|868|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-218|12|868|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-219|12|868|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-220|12|868|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-221|12|869|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-222|12|870|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-223|12|872|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-224|12|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases  tgac infilt. eyeball.Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-225|12|875|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-226|12|876|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-227|12|877|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-228|12|879|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-229|12|879|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-230|12|879|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-231|12|879|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-232|12|882|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILT. OF MUSCLE & LYSIS VERT. BONE.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-233|12|886|Neoplasia malignant|Bloodvessels among cardiovascular system|TSVS/ ventral lower abdomen.Skin|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-234|12|886|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-235|12|887|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-236|12|888|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-237|12|889|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-238|12|889|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-239|12|889|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-240|12|890|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-241|12|891|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-242|12|891|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-243|12|892|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-244|12|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-245|12|897|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-246|12|897|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-247|12|897|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ attached to urinary bladder.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-248|12|898|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-249|12|898|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILT. OF MUSCLE & LYSIS OF RIB BONE.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-250|12|900|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-251|12|900|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-252|12|901|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-253|12|902|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-254|12|902|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-255|12|903|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-256|12|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-257|12|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ w/ leukemia.,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-258|12|904|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-259|12|905|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-260|12|905|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-261|12|905|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWC: TCFS IN PT LN.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-262|12|906|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-263|12|906|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-264|12|907|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-265|12|908|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/   Metastases Kidney|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-266|12|908|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILT. OF MUSCLE & LYSIS VERT. BONE.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-267|12|908|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-268|12|910|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-269|12|911|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-270|12|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-271|12|912|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-272|12|912|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-273|12|913|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-274|12|914|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-275|12|915|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-276|12|915|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-277|12|916|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUEC/  squamous cell Ca Metastases  tuec on parietal perit & on visc perit of kidn.,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-278|12|917|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-279|12|919|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVASION OF MUSCLE.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-280|12|920|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-281|12|921|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-282|12|921|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-283|12|922|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-284|12|924|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-285|12|924|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-286|12|925|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-287|12|925|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-288|12|925|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-289|12|925|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-290|12|925|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWU: TULS TO LUNG.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-291|12|926|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-292|12|928|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-293|12|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-294|12|929|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXL/  Mixed histiocyt.leukemiaEye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-295|12|929|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-296|12|929|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Eye(s) missing Head/neck missing,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-297|12|930|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-298|12|931|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-299|12|932|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWU: TUEC ON PARIETAL PERIT & ON VISC PERIT OF KIDN.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-300|12|932|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-301|12|934|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-302|12|934|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ erythroblastic w/ leukemia.,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-303|12|936|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-304|12|938|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-305|12|938|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-306|12|938|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF MUSCLE.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-307|12|939|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-308|12|939|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-309|12|940|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-310|12|941|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-311|12|941|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-312|12|941|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-313|12|942|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-314|12|942|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-315|12|943|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-316|12|943|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-317|12|943|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-318|12|944|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-319|12|947|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-320|12|948|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-321|12|948|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-322|12|948|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-323|12|949|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-324|12|949|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-325|12|952|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-326|12|953|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-327|12|953|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-328|12|954|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-329|12|955|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-330|12|955|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-331|12|957|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-332|12|959|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-333|12|960|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-334|12|960|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-335|12|960|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-336|12|960|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-337|12|962|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-338|12|963|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-339|12|963|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-340|12|963|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-341|12|964|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-342|12|964|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-343|12|965|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-344|12|967|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-345|12|967|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-346|12|967|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-347|12|968|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-348|12|969|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-349|12|970|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-350|12|971|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-351|12|972|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-352|12|972|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-353|12|973|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-354|12|974|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-355|12|974|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-356|12|974|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-357|12|975|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-358|12|975|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-359|12|976|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-360|12|976|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-361|12|976|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-362|12|977|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-363|12|977|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-364|12|978|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-365|12|978|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-366|12|978|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-367|12|979|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-368|12|980|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUEC/ vagina.squamous cell Ca Metastases Lung,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-369|12|980|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-370|12|981|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-371|12|981|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-372|12|981|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-373|12|982|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-374|12|983|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-375|12|985|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-376|12|986|Neoplasia systemic|Haematolymphatic system|TLML/  Eye(s) missing Head/neck missing|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-377|12|986|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-378|12|986|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWS: TSVS INFILTR THIGH MUSC.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-379|12|987|Other deterministic changes|Whole body|MCDU/  Head/neck missing Eye(s) missing|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-380|12|987|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-381|12|987|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-382|12|988|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-383|12|988|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-384|12|989|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-385|12|991|Neoplasia unclassified|Other local manifestations and miscellaneus|THWA: TAPS TO LIVER.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-386|12|992|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-387|12|992|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-388|12|992|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-389|12|994|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-390|12|995|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-391|12|996|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-392|12|996|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-393|12|997|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-394|12|997|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TULS/   Metastases Lung Metastases  tuls to peritoneum.,MPATH: 551 - sarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-395|12|998|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-396|12|999|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAA/  Acidophilic adenoma,MPATH: 218 - neoplasm|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-397|12|999|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-398|12|999|Neoplasia unclassified|Other local manifestations and miscellaneus|TSWC: TCFS INFILT. OF SKIN.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-399|12|1000|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-400|12|1000|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-401|12|1000|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-402|12|1001|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-403|12|1002|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-404|12|1002|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-405|12|1003|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-406|12|1005|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-407|12|1005|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-408|12|1005|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-409|12|1006|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-410|12|1006|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-411|12|1006|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-412|12|1007|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-413|12|1007|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-414|12|1008|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-415|12|1008|Neoplasia unclassified|Other local manifestations and miscellaneus|TNWB: TBOS OF LUMBAR SPINE INFILTRATES SPINAL CORD.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-416|12|1008|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-417|12|1009|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-418|12|1009|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-419|12|1010|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-420|12|1011|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-421|12|1014|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-422|12|1015|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-423|12|1015|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-424|12|1016|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-425|12|1016|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/   Metastases  Muscle tbvs invades musc.,MPATH: 242 - hemangiosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-426|12|1016|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-427|12|1016|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-428|12|1017|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. left lateral. Metastases  Muscle tcfs infiltrates muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-429|12|1020|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-430|12|1021|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-431|12|1021|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-432|12|1022|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-433|12|1022|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-434|12|1023|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-435|12|1024|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-436|12|1026|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-437|12|1026|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-438|12|1026|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-439|12|1026|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-440|12|1028|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-441|12|1028|Neoplasia unclassified|Other local manifestations and miscellaneus|TNWB: TBOS OF LUMBAR SPINE INFILTRATES SPINAL CORD.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-442|12|1029|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-443|12|1030|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-444|12|1030|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-445|12|1031|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-446|12|1031|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-447|12|1031|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-448|12|1032|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing Trunk missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-449|12|1032|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-450|12|1032|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-451|12|1032|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-452|12|1033|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-453|12|1033|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-454|12|1034|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-455|12|1036|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-456|12|1037|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lumbar spine. Metastases  tbos of lumbar spine infiltrates spinal cord.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-457|12|1037|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-458|12|1037|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-459|12|1037|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-460|12|1038|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-461|12|1038|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-462|12|1039|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-463|12|1039|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-464|12|1039|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-465|12|1039|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-466|12|1039|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-467|12|1040|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILT. OF MUSCLE & LYSIS OF RIB BONE.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-468|12|1041|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-469|12|1042|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-470|12|1043|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-471|12|1043|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-472|12|1044|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-473|12|1045|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-474|12|1045|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-475|12|1045|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-476|12|1047|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-477|12|1047|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-478|12|1048|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-479|12|1050|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-480|12|1051|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-481|12|1052|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-482|12|1053|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-483|12|1053|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-484|12|1053|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-485|12|1054|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-486|12|1054|Neoplasia systemic|Haematolymphatic system|TLML/  Head/neck missing Eye(s) missing|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-487|12|1054|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-488|12|1055|Neoplasia systemic|Haematolymphatic system|TLPS/  Eye(s) missing Head/neck missing|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-489|12|1055|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-490|12|1055|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-491|12|1058|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-492|12|1058|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-493|12|1058|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-494|12|1058|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-495|12|1060|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-496|12|1060|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-497|12|1060|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWG: TGAC INFILT. EYEBALL.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-498|12|1061|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-499|12|1061|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-500|12|1061|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-501|12|1062|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-502|12|1062|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-503|12|1063|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-504|12|1063|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVADES MUSCLE.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-505|12|1065|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-506|12|1066|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-507|12|1070|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-508|12|1072|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ large mass in pelvic reg.&sm. mass on capsule of spleen. Metastases  Muscle tcfs invasion of muscle.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-509|12|1072|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-510|12|1072|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-511|12|1074|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-512|12|1074|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-513|12|1075|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-514|12|1075|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-515|12|1075|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-516|12|1076|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-517|12|1077|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-518|12|1078|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-519|12|1081|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-520|12|1081|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-521|12|1082|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-522|12|1083|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-523|12|1083|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-524|12|1084|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-525|12|1084|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-526|12|1084|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-527|12|1084|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-528|12|1086|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-529|12|1089|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-530|12|1089|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-531|12|1090|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-532|12|1091|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-533|12|1093|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-534|12|1093|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. dorsal & left lateral thor. & abd. Metastases  Muscle tcfs invas. of skel. muscle. Metastases  Lymphoret.System tcfs in pt ln.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-535|12|1094|Neoplasia unclassified|Other local manifestations and miscellaneus|TSWC: TCFS INFILTR. OF SKIN WITH ULCERATION.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-536|12|1095|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-537|12|1095|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-538|12|1096|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-539|12|1096|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-540|12|1098|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAC/ with muscle & connective tissue infiltration.,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-541|12|1100|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWU: TUEC ON PARIETAL PERIT & ON VISC PERIT OF KIDN.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-542|12|1100|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-543|12|1104|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-544|12|1106|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-545|12|1106|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-546|12|1107|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-547|12|1108|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-548|12|1108|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-549|12|1110|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-550|12|1113|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-551|12|1113|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWC: TCFS IN PT LN.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-552|12|1113|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-553|12|1114|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF MUSCLE-DORSAL.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-554|12|1115|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-555|12|1115|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-556|12|1115|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-557|12|1116|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-558|12|1117|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-559|12|1117|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-560|12|1117|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILT. OF MUSCLE & LYSIS OF RIB BONE.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-561|12|1118|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-562|12|1118|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-563|12|1121|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-564|12|1121|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-565|12|1121|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-566|12|1122|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-567|12|1122|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-568|12|1122|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-569|12|1123|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-570|12|1123|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-571|12|1123|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-572|12|1125|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-573|12|1125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-574|12|1127|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-575|12|1128|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-576|12|1128|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-577|12|1129|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-578|12|1131|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWR: TRAC TO VISCERAL PLEURA.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-579|12|1132|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-580|12|1133|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-581|12|1135|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/   Metastases  Muscle tcfs invades muscle.,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-582|12|1135|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-583|12|1136|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-584|12|1138|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-585|12|1141|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-586|12|1141|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-587|12|1143|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-588|12|1143|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-589|12|1147|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-590|12|1148|Neoplasia systemic|Haematolymphatic system|TLPS/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-591|12|1148|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-592|12|1148|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-593|12|1149|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. on belly. Metastases  Skin tcfs infilt. of skin.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-594|12|1150|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-595|12|1151|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-596|12|1152|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-597|12|1152|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-598|12|1153|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-599|12|1155|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-600|12|1155|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-601|12|1156|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-602|12|1157|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-603|12|1157|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-604|12|1159|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-605|12|1160|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-606|12|1161|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-607|12|1162|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-608|12|1162|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-609|12|1162|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-610|12|1164|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-611|12|1164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-612|12|1165|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-613|12|1165|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-614|12|1166|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-615|12|1166|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-616|12|1168|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-617|12|1169|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-618|12|1170|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-619|12|1170|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-620|12|1172|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-621|12|1173|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-622|12|1174|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-623|12|1174|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-624|12|1175|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-625|12|1176|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-626|12|1176|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-627|12|1177|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-628|12|1177|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWG: TGAC INFILT. EYEBALL.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-629|12|1177|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-630|12|1177|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-631|12|1178|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-632|12|1180|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-633|12|1180|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-634|12|1180|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-635|12|1181|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-636|12|1181|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-637|12|1182|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-638|12|1183|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-639|12|1184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-640|12|1185|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-641|12|1186|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-642|12|1187|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-643|12|1187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-644|12|1189|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-645|12|1190|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-646|12|1191|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-647|12|1191|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-648|12|1191|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-649|12|1192|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-650|12|1192|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-651|12|1193|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-652|12|1194|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-653|12|1196|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-654|12|1198|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-655|12|1199|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. dorsal lumbar region.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-656|12|1200|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-657|12|1202|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-658|12|1202|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-659|12|1205|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-660|12|1207|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-661|12|1209|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-662|12|1211|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-663|12|1211|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-664|12|1214|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-665|12|1215|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-666|12|1215|Neoplasia benign|Bloodvessels among cardiovascular system|TCVO/ between kidneys.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-667|12|1216|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-668|12|1219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-669|12|1220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-670|12|1220|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-671|12|1220|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-672|12|1221|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-673|12|1221|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to visceral pleura.,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-674|12|1221|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-675|12|1222|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|TNMS/  ,MPATH: 551 - sarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-676|12|1226|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-677|12|1226|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-678|12|1230|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-679|12|1230|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-680|12|1230|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Liver,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-681|12|1234|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-682|12|1235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-683|12|1236|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-684|12|1237|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-685|12|1237|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-686|12|1239|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-687|12|1241|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ on ribs of rt. side and subcut. left abd. Metastases  tcfs metast. to visc. peritoneum -kid. Metastases  Muscle tcfs infilt. of muscle & lysis of rib bone.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-688|12|1242|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-689|12|1242|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. on back in thoracic reg. Metastases  Muscle tcfs infilt. of muscle & lysis vert. bone.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-690|12|1244|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-691|12|1244|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-692|12|1245|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-693|12|1247|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-694|12|1249|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-695|12|1250|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-696|12|1251|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-697|12|1256|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-698|12|1256|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ 2 sites-subcut. dorsal thoracic reg. & subcut. left axilla. Metastases  Muscle tcfs invas. of muscle-dorsal.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-699|12|1257|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-700|12|1260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-701|12|1261|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-702|12|1263|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-703|12|1265|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-704|12|1265|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-705|12|1266|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-706|12|1268|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-707|12|1268|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-708|12|1269|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-709|12|1274|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-710|12|1274|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-711|12|1275|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-712|12|1275|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-713|12|1275|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-714|12|1278|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-715|12|1286|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-716|12|1288|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-717|12|1292|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-718|12|1297|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-719|12|1301|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. on top of head. Metastases  Muscle tcfs invas. of muscle. Metastases  Skin tcfs invas. of skin.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-720|12|1305|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-721|12|1310|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-722|12|1311|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-723|12|1312|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-724|12|1313|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-725|12|1314|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-726|12|1315|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-727|12|1316|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-728|12|1318|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-729|12|1320|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-730|12|1321|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWS: TSVS INFILTR THIGH MUSC.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-731|12|1324|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-732|12|1333|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-733|12|1334|Other deterministic changes|Whole body|MCDU/|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-734|12|1338|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-735|12|1341|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-736|12|1345|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-737|12|1349|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-738|12|1350|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC METAST. TO PT LN.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-739|12|1352|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Lymphoret.System trac metast. to pt ln.,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-740|12|1359|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-741|12|1366|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-742|12|1387|Other deterministic changes|Whole body|MCDU/   Metastases  Muscle tcfs invas. of muscle.|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-743|12|1390|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-744|12|1391|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-745|12|1407|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-746|12|1410|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-747|12|1420|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-748|12|1425|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-749|12|1435|n/a|n/a|n/a|
1003-26-12|n/a,X4|1|100|neutrons fission|0.01|grays|External exposure|code X4 1 fraction 20 m|750 (750 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|735 records survival 859 ± 7 lifespan study|1003-26-12-750|12|1444|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-1|13|115|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-2|13|115|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-3|13|115|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-4|13|115|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-5|13|115|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-6|13|360|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-7|13|473|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-8|13|478|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ rib. Metastases  tbos of rib to mediastinum & tiss around heart.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-9|13|489|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-10|13|491|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-11|13|498|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-12|13|501|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUUS/   Metastases  tuus invades peritoneum. Metastases Lung Metastases Ovary Metastases Liver,MPATH: 255 - adenoacanthoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-13|13|519|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases Kidney,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-14|13|544|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-15|13|555|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-16|13|560|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-17|13|563|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-18|13|570|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-19|13|573|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-20|13|582|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-21|13|588|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-22|13|592|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-23|13|610|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-24|13|624|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-25|13|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-26|13|635|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-27|13|636|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-28|13|639|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAA/   Metastases Lung tmaa to lung.,MPATH: 218 - neoplasm|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-29|13|641|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-30|13|668|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-31|13|670|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-32|13|676|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-33|13|685|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-34|13|686|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-35|13|686|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-36|13|686|Neoplasia systemic|Haematolymphatic system|TLML/ non-leukemic|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-37|13|690|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-38|13|700|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-39|13|705|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-40|13|705|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-41|13|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-42|13|707|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-43|13|710|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-44|13|715|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-45|13|721|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-46|13|722|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-47|13|725|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-48|13|725|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-49|13|731|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-50|13|733|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-51|13|735|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-52|13|743|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-53|13|743|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-54|13|745|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-55|13|746|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-56|13|747|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-57|13|750|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-58|13|752|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-59|13|753|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-60|13|756|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-61|13|756|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-62|13|758|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-63|13|758|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-64|13|761|Neoplasia benign|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVO/  Thorax missing Head/neck missing Eye(s) missing,MPATH: 240 - hemangioma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-65|13|764|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-66|13|766|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-67|13|766|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-68|13|772|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-69|13|775|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-70|13|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-71|13|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-72|13|779|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-73|13|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-74|13|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-75|13|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSL/  undifferentiated leukemia lymphoret.tissue,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-76|13|792|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-77|13|793|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-78|13|794|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-79|13|796|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-80|13|797|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-81|13|799|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-82|13|799|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-83|13|801|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-84|13|803|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-85|13|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-86|13|804|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-87|13|807|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ on the back-- extensive.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-88|13|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-89|13|813|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-90|13|813|Other deterministic changes|Whole body|MCDU/  Eye(s) missing Head/neck missing|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-91|13|813|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-92|13|815|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-93|13|815|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|TSEC/ skin of nose.,MPATH: 218 - neoplasm|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-94|13|816|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-95|13|819|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-96|13|821|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-97|13|823|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-98|13|824|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-99|13|824|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-100|13|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-101|13|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-102|13|829|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|TIEC/ esophagus.,MPATH: 549 - carcinoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-103|13|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-104|13|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ w/ leukemia.,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-105|13|833|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-106|13|833|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-107|13|833|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-108|13|836|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-109|13|837|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-110|13|837|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-111|13|837|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-112|13|838|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-113|13|838|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-114|13|840|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-115|13|840|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF JAW INVASION OF MUSCLE.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-116|13|842|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-117|13|843|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-118|13|850|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-119|13|851|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-120|13|853|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-121|13|855|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-122|13|855|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-123|13|855|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-124|13|855|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-125|13|855|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-126|13|856|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-127|13|857|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-128|13|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-129|13|858|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-130|13|862|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-131|13|863|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-132|13|863|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-133|13|864|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-134|13|865|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-135|13|866|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-136|13|867|Neoplasia unclassified|Other local manifestations and miscellaneus|TSWC: TCFS OF HEAD AND NECK INVAS. OF SKIN ON HEAD & NECK.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-137|13|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-138|13|868|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-139|13|868|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-140|13|869|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-141|13|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-142|13|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-143|13|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-144|13|876|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-145|13|877|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-146|13|877|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-147|13|877|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-148|13|880|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-149|13|881|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-150|13|881|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-151|13|883|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-152|13|885|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-153|13|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-154|13|889|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-155|13|890|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-156|13|890|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-157|13|894|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-158|13|895|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-159|13|896|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-160|13|896|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-161|13|896|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-162|13|897|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-163|13|897|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWZ: TZAC TO LUNG.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-164|13|898|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-165|13|898|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-166|13|901|Neoplasia malignant|Bloodvessels among cardiovascular system|TSVS/ left femur.Skin|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-167|13|902|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-168|13|902|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-169|13|904|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-170|13|905|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-171|13|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-172|13|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-173|13|906|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-174|13|908|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-175|13|909|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-176|13|910|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-177|13|912|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-178|13|913|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-179|13|913|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-180|13|915|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-181|13|918|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-182|13|919|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-183|13|919|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-184|13|920|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-185|13|920|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ with leukemia.,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-186|13|920|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-187|13|921|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-188|13|921|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-189|13|922|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-190|13|925|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-191|13|926|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-192|13|926|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lt femur.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-193|13|927|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-194|13|929|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. left lateral thoracic region.Head/neck missing Eye(s) missing,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-195|13|930|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILT. OF MUSCLE & SKIN.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-196|13|933|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-197|13|933|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to spleen. Metastases Kidney,MPATH: 268 - adenocarcinoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-198|13|933|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-199|13|934|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-200|13|935|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-201|13|935|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-202|13|936|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases  Muscle tsec of nose infiltrates musc of nose.,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-203|13|936|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-204|13|937|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-205|13|938|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-206|13|938|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-207|13|942|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-208|13|942|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-209|13|944|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-210|13|946|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWS: TSEC OF NOSE INFILTRATES MUSC OF NOSE.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-211|13|946|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-212|13|948|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-213|13|948|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-214|13|949|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-215|13|949|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-216|13|950|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-217|13|950|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-218|13|951|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-219|13|952|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-220|13|953|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-221|13|953|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-222|13|954|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-223|13|956|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-224|13|957|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-225|13|959|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-226|13|959|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-227|13|959|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-228|13|959|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-229|13|965|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-230|13|966|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-231|13|966|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-232|13|968|Neoplasia unclassified|Other local manifestations and miscellaneus|TSWC: TCFS OF HEAD AND NECK INVAS. OF SKIN ON HEAD & NECK.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-233|13|969|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-234|13|970|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-235|13|971|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-236|13|972|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-237|13|973|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-238|13|976|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-239|13|976|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases  Muscle trac to muscles of thorax.,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-240|13|979|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-241|13|980|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-242|13|980|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-243|13|980|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-244|13|981|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-245|13|981|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-246|13|982|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-247|13|982|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-248|13|983|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-249|13|983|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-250|13|984|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-251|13|984|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-252|13|986|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-253|13|987|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-254|13|988|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-255|13|988|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-256|13|989|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-257|13|990|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-258|13|990|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-259|13|999|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-260|13|999|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-261|13|1001|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-262|13|1002|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-263|13|1002|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-264|13|1007|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-265|13|1007|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-266|13|1007|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-267|13|1010|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-268|13|1012|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-269|13|1013|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-270|13|1014|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-271|13|1015|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-272|13|1018|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-273|13|1018|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-274|13|1019|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|TZAC/  ,MPATH: 278 - follicular adenocarcinoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-275|13|1019|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-276|13|1021|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-277|13|1024|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-278|13|1026|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-279|13|1028|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-280|13|1030|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-281|13|1030|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ left thigh.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-282|13|1030|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-283|13|1034|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-284|13|1036|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-285|13|1037|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-286|13|1039|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-287|13|1039|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-288|13|1040|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-289|13|1040|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-290|13|1041|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-291|13|1042|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-292|13|1044|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-293|13|1044|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-294|13|1044|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-295|13|1045|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-296|13|1045|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-297|13|1047|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-298|13|1048|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thigh muscle.Eye(s) missing Head/neck missing|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-299|13|1049|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-300|13|1050|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-301|13|1050|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-302|13|1051|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-303|13|1051|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-304|13|1051|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-305|13|1052|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-306|13|1053|Inflammation and/or fibrotic diseases|Lower digestive tract,MA: 0000328 - intestine|MIIA/ anal prolapse.Enteritis acute,MPATH: 212 - inflammation|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-307|13|1053|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-308|13|1053|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-309|13|1054|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ along lumbar spine with invasion of adj. vertebrae. Muscle|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-310|13|1057|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-311|13|1057|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-312|13|1059|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-313|13|1060|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-314|13|1064|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-315|13|1066|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIC/  chronic hepatitis,MPATH: 212 - inflammation|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-316|13|1066|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-317|13|1067|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-318|13|1068|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-319|13|1068|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-320|13|1069|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-321|13|1073|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-322|13|1074|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-323|13|1074|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-324|13|1074|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-325|13|1074|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-326|13|1079|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-327|13|1080|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-328|13|1080|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-329|13|1080|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-330|13|1083|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-331|13|1084|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-332|13|1085|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-333|13|1085|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-334|13|1090|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-335|13|1091|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-336|13|1092|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-337|13|1092|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-338|13|1093|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-339|13|1093|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-340|13|1093|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-341|13|1093|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-342|13|1093|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-343|13|1094|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. right side. Metastases  Muscle tcfs infilt. of muscle & skin.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-344|13|1096|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-345|13|1097|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-346|13|1097|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-347|13|1101|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-348|13|1101|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-349|13|1101|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-350|13|1102|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-351|13|1103|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-352|13|1103|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-353|13|1105|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-354|13|1105|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-355|13|1110|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-356|13|1114|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-357|13|1119|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-358|13|1120|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-359|13|1123|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-360|13|1123|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF JAW INVASION OF MUSCLE.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-361|13|1124|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-362|13|1128|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-363|13|1131|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-364|13|1135|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-365|13|1135|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-366|13|1137|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-367|13|1138|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-368|13|1139|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-369|13|1139|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-370|13|1140|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-371|13|1142|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-372|13|1144|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-373|13|1144|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-374|13|1145|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-375|13|1145|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-376|13|1146|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-377|13|1147|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-378|13|1152|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-379|13|1154|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-380|13|1155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-381|13|1155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-382|13|1156|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-383|13|1157|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-384|13|1157|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-385|13|1162|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-386|13|1163|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-387|13|1164|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  Head/neck missing|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-388|13|1169|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-389|13|1170|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-390|13|1175|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-391|13|1177|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-392|13|1177|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-393|13|1184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-394|13|1185|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-395|13|1186|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-396|13|1188|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ on head & neck behind right ear.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-397|13|1188|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-398|13|1188|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-399|13|1191|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-400|13|1191|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-401|13|1191|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-402|13|1194|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-403|13|1195|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-404|13|1198|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-405|13|1199|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-406|13|1202|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-407|13|1205|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-408|13|1205|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-409|13|1209|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-410|13|1209|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-411|13|1216|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-412|13|1219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  Skin tcfs of head and neck invas. of skin on head & neck.,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-413|13|1220|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-414|13|1221|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lumbar spine with infiltr. of muscle & lysis of bone.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-415|13|1233|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-416|13|1234|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-417|13|1240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-418|13|1242|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-419|13|1244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-420|13|1244|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-421|13|1251|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-422|13|1253|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-423|13|1253|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-424|13|1258|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-425|13|1261|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ left face-jaw-with lysis of bone. Metastases  Muscle tbos of jaw invasion of muscle.|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-426|13|1265|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-427|13|1269|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-428|13|1276|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-429|13|1278|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-430|13|1281|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-431|13|1297|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-432|13|1307|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-433|13|1309|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-434|13|1318|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-435|13|1324|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-436|13|1327|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-437|13|1336|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-438|13|1341|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-439|13|1355|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-440|13|1356|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-441|13|1363|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-442|13|1365|Other deterministic changes|Whole body|MCDU/|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-443|13|1375|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-444|13|1377|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-445|13|1378|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-446|13|1382|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-447|13|1395|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-448|13|1418|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|TZAC/   Metastases Lung Metastases Heart,MPATH: 278 - follicular adenocarcinoma|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-449|13|1421|n/a|n/a|n/a|
1003-26-13|n/a,X5|1|100|neutrons fission|0.025|grays|External exposure|code X5 1 fraction 20 m|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|445 records survival 848 ± 9 lifespan study|1003-26-13-450|13|1424|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-1|14|131|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-2|14|157|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-3|14|177|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-4|14|190|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-5|14|234|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-6|14|296|Other deterministic changes|Whole body|MCDU/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-7|14|334|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-8|14|420|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-9|14|463|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-10|14|512|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-11|14|521|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-12|14|528|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  Lymphoret.System tcfs invas. of abd. ln.,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-13|14|534|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-14|14|536|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-15|14|543|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-16|14|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-17|14|553|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-18|14|561|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-19|14|576|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|TMAT/  ,MPATH: 255 - adenoacanthoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-20|14|579|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ in skull. Metastases Liver|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-21|14|600|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-22|14|607|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-23|14|610|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWB: TBOS OF FEMUR AND LUMBAR SPINE TO LUNG.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-24|14|612|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-25|14|620|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-26|14|620|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-27|14|621|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-28|14|630|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-29|14|632|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-30|14|641|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-31|14|645|Neoplasia benign|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAO/ papilloma, ureter with occlusion.,MPATH: 270 - adenoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-32|14|653|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-33|14|664|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-34|14|664|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-35|14|666|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-36|14|666|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-37|14|680|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-38|14|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-39|14|710|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-40|14|710|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-41|14|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-42|14|713|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-43|14|718|Other deterministic changes|Whole body|MCDU/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-44|14|721|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-45|14|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-46|14|731|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-47|14|737|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-48|14|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-49|14|749|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-50|14|750|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-51|14|750|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-52|14|752|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-53|14|753|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/ invades peritoneum.,MPATH: 242 - hemangiosarcoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-54|14|756|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO SKELETAL MUSCLES OF CHEST.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-55|14|757|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal Metastases Lung tmab mammary to lung.,MPATH: 218 - neoplasm|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-56|14|757|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-57|14|757|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MMTA/  Metritis|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-58|14|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-59|14|761|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-60|14|763|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-61|14|764|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-62|14|764|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-63|14|769|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-64|14|771|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-65|14|776|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-66|14|778|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-67|14|779|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-68|14|781|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-69|14|783|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-70|14|784|Other deterministic changes|Whole body|MCDU/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-71|14|784|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-72|14|785|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-73|14|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  Thorax missing Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-74|14|791|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-75|14|792|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-76|14|792|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-77|14|798|Other deterministic changes|Whole body|MCDU/  Eye(s) missing Head/neck missing|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-78|14|806|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-79|14|806|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWU: TULS INVAS. OF VISC. PERIT. OF UTERUS AND GUT.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-80|14|806|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-81|14|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-82|14|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-83|14|820|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-84|14|820|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-85|14|820|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-86|14|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-87|14|821|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-88|14|826|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-89|14|827|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-90|14|830|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ rt femur & lumbar spine. Metastases Lung|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-91|14|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-92|14|834|Other deterministic changes|Lower respiratory system|MPNC/  Lung congestion|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-93|14|834|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-94|14|834|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-95|14|836|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-96|14|837|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-97|14|840|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-98|14|841|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-99|14|844|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-100|14|847|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-101|14|849|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-102|14|855|Other deterministic changes|Whole body|MCDU/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-103|14|856|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ femur|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-104|14|857|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-105|14|857|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-106|14|859|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-107|14|863|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-108|14|865|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to cn ln.,MPATH: 268 - adenocarcinoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-109|14|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ w/ leukemia.,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-110|14|873|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-111|14|876|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-112|14|879|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-113|14|884|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-114|14|885|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-115|14|885|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-116|14|887|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|MTHR/  auricular|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-117|14|889|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-118|14|890|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-119|14|892|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-120|14|893|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-121|14|896|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-122|14|901|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-123|14|904|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-124|14|905|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-125|14|906|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  Thorax missing Eye(s) missing Head/neck missing,MPATH: 242 - hemangiosarcoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-126|14|906|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-127|14|910|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ lt forelimb.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-128|14|912|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-129|14|913|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-130|14|913|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal,MPATH: 218 - neoplasm|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-131|14|913|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-132|14|914|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-133|14|915|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-134|14|918|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-135|14|919|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-136|14|922|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-137|14|922|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-138|14|922|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-139|14|924|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-140|14|924|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-141|14|925|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-142|14|927|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-143|14|928|Neoplasia systemic|Haematolymphatic system|TLPS/  Head/neck missing Eye(s) missing Thorax missing|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-144|14|928|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-145|14|929|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-146|14|929|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-147|14|929|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lower spine & rt femur.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-148|14|929|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-149|14|930|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-150|14|931|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-151|14|932|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-152|14|932|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-153|14|933|Neoplasia unclassified|Other local manifestations and miscellaneus|THWB: TBOS OF PELVIS TO LIVER.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-154|14|934|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-155|14|935|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-156|14|936|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-157|14|938|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-158|14|939|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-159|14|940|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-160|14|941|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-161|14|943|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-162|14|943|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-163|14|943|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-164|14|943|Other deterministic changes|Whole body|MCDU/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-165|14|944|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TULS/   Metastases  tuls invas. of visc. perit. of uterus and gut.,MPATH: 551 - sarcoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-166|14|945|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-167|14|946|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWA: TAPS TO LUNG.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-168|14|947|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWC: TCFS OF JAW METAST TO CERVICAL NODES.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-169|14|948|Neoplasia systemic|Haematolymphatic system|TLPS/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-170|14|948|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-171|14|949|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-172|14|950|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-173|14|953|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-174|14|954|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-175|14|959|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-176|14|959|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-177|14|960|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-178|14|960|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-179|14|961|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-180|14|961|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-181|14|963|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-182|14|963|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases Lung tmat (mamm) to lung.,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-183|14|963|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-184|14|964|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-185|14|964|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-186|14|965|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ dorsal lumbar region.Thorax missing Eye(s) missing Head/neck missing|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-187|14|970|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-188|14|972|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-189|14|973|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-190|14|974|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-191|14|974|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-192|14|976|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-193|14|978|Other deterministic changes|Whole body|MCDU/  Eye(s) missing Head/neck missing|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-194|14|978|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-195|14|979|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-196|14|982|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-197|14|982|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-198|14|983|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-199|14|985|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-200|14|986|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-201|14|993|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-202|14|993|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-203|14|994|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWU: TULS INVAS. OF VISC. PERIT. OF UTERUS AND GUT.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-204|14|995|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-205|14|996|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-206|14|996|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-207|14|996|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-208|14|997|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-209|14|997|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXL/  Mixed histiocyt.leukemia,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-210|14|1001|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-211|14|1002|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-212|14|1002|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-213|14|1003|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-214|14|1003|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-215|14|1005|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-216|14|1006|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-217|14|1007|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-218|14|1007|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-219|14|1008|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases  tcvs in skull invades brain.,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-220|14|1009|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-221|14|1011|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-222|14|1012|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-223|14|1012|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ pelvis. Metastases Lung Metastases  Muscle tbos of pelvis invas. of muscle.Head/neck missing Thorax missing Eye(s) missing|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-224|14|1014|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-225|14|1015|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-226|14|1016|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-227|14|1016|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-228|14|1019|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-229|14|1019|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MMTA/  Metritis Metastases  Skin tcfs of jaw metast to skin of jaw. Metastases  Muscle tcfs of jaw metast to musc of jaw. Metastases  tcfs of jaw metast to panc. Metastases  Lymphoret.System tcfs of jaw metast to cervical nodes.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-230|14|1025|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-231|14|1025|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-232|14|1026|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-233|14|1027|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-234|14|1030|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-235|14|1031|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-236|14|1032|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWC: TCFS INVAS. OF ABD. LN.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-237|14|1033|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-238|14|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-239|14|1036|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-240|14|1037|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-241|14|1038|Other deterministic changes|Whole body|MCDU/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-242|14|1039|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-243|14|1039|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-244|14|1039|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-245|14|1040|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-246|14|1040|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-247|14|1041|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-248|14|1041|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-249|14|1042|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-250|14|1045|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-251|14|1046|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-252|14|1048|Neoplasia unclassified|Other local manifestations and miscellaneus|THWB: TBOS OF PELVIS TO LIVER.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-253|14|1048|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-254|14|1049|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-255|14|1051|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MMTA/  Metritis|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-256|14|1051|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-257|14|1051|Neoplasia unclassified|Other local manifestations and miscellaneus|THWB: TBOS OF PELVIS TO LIVER.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-258|14|1053|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-259|14|1053|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-260|14|1057|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-261|14|1058|Other deterministic changes|Whole body|MCDU/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-262|14|1062|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-263|14|1063|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-264|14|1064|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-265|14|1064|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-266|14|1066|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-267|14|1066|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-268|14|1069|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-269|14|1076|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-270|14|1079|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-271|14|1082|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-272|14|1084|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-273|14|1085|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-274|14|1087|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-275|14|1090|Other deterministic changes|Whole body|MCDU/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-276|14|1092|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-277|14|1094|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-278|14|1097|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-279|14|1098|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-280|14|1098|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-281|14|1100|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  Head/neck missing Eye(s) missing|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-282|14|1102|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-283|14|1103|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-284|14|1103|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-285|14|1106|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-286|14|1110|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-287|14|1111|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-288|14|1114|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-289|14|1114|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-290|14|1119|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-291|14|1119|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO CN LN.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-292|14|1121|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-293|14|1121|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-294|14|1125|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-295|14|1127|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-296|14|1133|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-297|14|1137|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-298|14|1139|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-299|14|1139|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-300|14|1147|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-301|14|1154|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-302|14|1155|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-303|14|1159|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-304|14|1159|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-305|14|1163|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-306|14|1164|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-307|14|1164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-308|14|1167|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-309|14|1170|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-310|14|1170|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-311|14|1171|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MCIG/ sec. to cystitis.,MPATH: 213 - acute inflammation|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-312|14|1171|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-313|14|1175|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-314|14|1176|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-315|14|1177|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt ln. Metastases Heart,MPATH: 268 - adenocarcinoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-316|14|1178|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-317|14|1185|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-318|14|1186|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-319|14|1187|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-320|14|1190|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-321|14|1190|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-322|14|1190|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-323|14|1191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-324|14|1197|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-325|14|1208|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Lung,MPATH: 268 - adenocarcinoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-326|14|1214|Other deterministic changes|Whole body|MCDU/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-327|14|1216|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-328|14|1216|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. right inguinal region. Metastases  Muscle tcfs invas. of muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-329|14|1219|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-330|14|1224|Other deterministic changes|Whole body|MCDU/  Head/neck missing|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-331|14|1237|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-332|14|1237|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-333|14|1239|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-334|14|1240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-335|14|1243|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-336|14|1257|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-337|14|1265|Neoplasia malignant|Endocrine system|TGAC/ infiltrat. of skin. Metastases Lung|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-338|14|1275|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-339|14|1278|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-340|14|1288|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-341|14|1290|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-342|14|1295|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-343|14|1303|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases Lung Metastases  trac to mediastinum. Metastases  Muscle trac to skeletal muscles of chest.,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-344|14|1306|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-345|14|1318|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-346|14|1366|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-347|14|1398|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-348|14|1416|n/a|n/a|n/a|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-349|14|1419|Other deterministic changes|Whole body|MCDU/|
1003-26-14|n/a,X6|1|100|neutrons fission|0.05|grays|External exposure|code X6 1 fraction 20 m|350 (350 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|349 records survival 822 ±  11 lifespan study|1003-26-14-350|14|1443|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-1|15|148|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWM: TMLS INVAS. OF BONE & GROWING ON CAPSULAR SURFACE OF KIDNEY.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-2|15|176|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-4|15|402|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-5|15|410|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-8|15|442|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-12|15|472|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-13|15|488|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-14|15|491|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWU: TUVS INFILT OF PELVIC PERIT.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-19|15|548|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-20|15|549|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-21|15|549|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-22|15|549|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-23|15|549|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-24|15|549|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-27|15|568|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-28|15|572|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-30|15|577|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-31|15|584|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-32|15|586|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-33|15|590|Other deterministic changes|Whole body|MCDU/|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-34|15|591|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-36|15|596|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-38|15|602|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-39|15|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-40|15|609|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INFILTRATES MUSCLE & SKIN.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-41|15|621|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lumbar spine.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-42|15|622|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-43|15|631|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-49|15|655|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-50|15|656|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-52|15|660|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-56|15|663|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-58|15|664|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-59|15|666|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-60|15|666|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-61|15|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-62|15|679|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-63|15|682|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUUS/  ,MPATH: 255 - adenoacanthoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-66|15|692|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-68|15|700|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-69|15|701|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-70|15|703|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-73|15|709|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-75|15|716|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-78|15|726|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-80|15|733|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-81|15|734|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-83|15|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSS/  undifferentiated lymphoma,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-85|15|742|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-89|15|746|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-90|15|750|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-92|15|757|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-94|15|762|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-99|15|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-103|15|780|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-104|15|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-105|15|790|Other deterministic changes|Whole body|MCDU/|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-106|15|793|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-107|15|795|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-108|15|795|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-110|15|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-111|15|802|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TMFS/ upper arm & shoulder.muscle,MPATH: 408 - soft tissue fibrosarcoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-112|15|804|Neoplasia malignant|Bloodvessels among cardiovascular system|TNVS/ brain.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-114|15|809|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-115|15|811|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-116|15|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-119|15|819|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-120|15|823|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-121|15|823|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-122|15|824|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-123|15|827|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-128|15|831|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-129|15|833|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|TMRS/ tail base causing pressure atrophy on colon.,MPATH: 428 - rhabdomyosarcoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-132|15|835|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-135|15|839|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-136|15|839|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-137|15|841|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVS/   Metastases  tuvs infilt of pelvic perit.,MPATH: 242 - hemangiosarcoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-138|15|842|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-139|15|842|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-140|15|843|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-141|15|845|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-142|15|846|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-143|15|849|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-144|15|849|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-147|15|851|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-149|15|859|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-151|15|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-152|15|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-153|15|864|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-154|15|866|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-156|15|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-157|15|869|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-159|15|871|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-161|15|873|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-163|15|876|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-166|15|880|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-167|15|880|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-168|15|880|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-169|15|880|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-171|15|887|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-174|15|890|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-175|15|890|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-176|15|890|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-178|15|892|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ with leukemia.,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-179|15|894|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-180|15|894|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-181|15|895|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-183|15|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-185|15|899|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-189|15|904|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-190|15|909|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-191|15|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-193|15|915|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-196|15|917|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-197|15|917|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-199|15|921|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-200|15|921|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-202|15|923|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-205|15|925|Other deterministic changes|Whole body|MCDU/|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-206|15|925|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-207|15|926|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-208|15|926|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-211|15|930|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INFILTRATES MUSCLE & SKIN.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-212|15|932|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-213|15|932|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  Head/neck missing|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-215|15|935|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ in thorax next to spine.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-216|15|935|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-217|15|937|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-218|15|939|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC TO CN LN.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-221|15|943|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-222|15|944|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-223|15|944|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-224|15|945|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-225|15|947|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVS/   Metastases  Muscle tcvs in thorax infiltrates muscle.,MPATH: 242 - hemangiosarcoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-226|15|947|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-227|15|949|Neoplasia malignant|Other local manifestations and miscellaneus|TCSS/ TCSS/ TCSS/ TCSS/ rt forelimb & myxomatous. Metastases  tcss invas of salivary gl.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-229|15|951|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-231|15|954|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-232|15|954|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-235|15|959|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-236|15|960|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-240|15|963|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-241|15|965|Neoplasia malignant|Other local manifestations and miscellaneus|TCSS/ TCSS/ TCSS/ TCSS/ subcut. in right shoulder & axillary region.Thorax missing|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-243|15|967|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-244|15|967|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-245|15|971|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-246|15|971|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-247|15|972|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-248|15|972|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-249|15|974|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ under left kidney. Metastases  tmls invas. of bone & growing on capsular surface of kidney.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-252|15|980|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-254|15|983|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-255|15|984|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-256|15|984|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-258|15|986|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-259|15|986|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-260|15|987|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-263|15|992|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-264|15|993|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-267|15|1001|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-268|15|1002|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-269|15|1002|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-270|15|1003|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-271|15|1003|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-276|15|1010|Inflammation and/or fibrotic diseases|Heart among cardiovascular system,MA: 0000076 - heart endocardium|MECC/  Chronic valvular endocarditis,MPATH: 214 - chronic inflammation|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-277|15|1011|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Muscle tgac infiltrates muscle & skin.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-278|15|1012|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ calvarium.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-279|15|1018|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-280|15|1018|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-281|15|1018|Neoplasia benign|Bloodvessels among cardiovascular system|TCVO/ heart.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-282|15|1019|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-285|15|1022|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-287|15|1023|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-288|15|1024|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-292|15|1036|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWC: TCSS OF RT. SHOULDER AND AXILLARY REG. TO CN LN.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-295|15|1037|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-298|15|1039|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-299|15|1040|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-301|15|1043|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INFILTRATES MUSCLE & SKIN.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-302|15|1043|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-303|15|1043|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-306|15|1049|Other deterministic changes|Whole body|MCDU/|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-307|15|1051|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-308|15|1051|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-309|15|1052|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS IN THORAX INFILTRATES MUSCLE.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-310|15|1053|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Lymphoret.System tcss of rt. shoulder and axillary reg. to cn ln.,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-313|15|1058|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-314|15|1059|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-316|15|1061|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-318|15|1062|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-319|15|1068|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Lymphoret.System tgac to cn ln. Metastases Lung Metastases  Muscle tgac to skin & muscles surrounding eye.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-320|15|1068|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-323|15|1074|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-325|15|1075|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/ ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-326|15|1077|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-327|15|1078|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-328|15|1080|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-330|15|1088|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-332|15|1089|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-333|15|1093|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-334|15|1093|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-335|15|1094|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-336|15|1100|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INFILTR. OF MUSCLE AROUND EYE.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-338|15|1103|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ over lumbar spine between kidneys. Muscle|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-342|15|1112|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-343|15|1113|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ vert. of lumbar-sacral region. Metastases  Muscle tbos of vert. of lumbar-sac. reg. invas. of skel. muscle.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-346|15|1114|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-347|15|1114|Neoplasia systemic|Haematolymphatic system|TLML/  Head/neck missing|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-350|15|1117|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-351|15|1117|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-353|15|1119|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-354|15|1119|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-355|15|1120|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-357|15|1124|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ subcut. left axillary region. is it connective tissue or muscle? secondaries in mesenteries.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-358|15|1129|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-359|15|1132|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-360|15|1136|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-361|15|1136|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-362|15|1137|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ subcut. right inguinal region.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-363|15|1140|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-364|15|1142|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-365|15|1143|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Thorax missing Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-368|15|1145|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-369|15|1148|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWC: TCSS OF RT. SHOULDER AND AXILLARY REG. TO CN LN.|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-370|15|1148|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-371|15|1156|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-374|15|1158|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-375|15|1163|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-376|15|1165|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-377|15|1165|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-378|15|1177|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-379|15|1178|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-380|15|1179|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-381|15|1190|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-384|15|1210|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-385|15|1215|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Muscle tcfs of right forelimb infiltr. skel. musc.,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-386|15|1216|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-387|15|1220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-388|15|1229|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-390|15|1263|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-391|15|1264|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-392|15|1268|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/   Metastases  Muscle tcfs infiltr. of muscle around eye.,MPATH: 242 - hemangiosarcoma|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-393|15|1278|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-394|15|1283|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-395|15|1284|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-396|15|1310|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-397|15|1310|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-398|15|1326|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-399|15|1326|n/a|n/a|n/a|
1003-26-15|n/a,X7|1|100|neutrons fission|0.1|grays|External exposure|code X7 1 fraction 20 m|250 (250 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|245 records survival 805 ± 13 lifespan study|1003-26-15-400|15|1420|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-1|16|248|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXUO/ teratoma, benign, ovary.,MPATH: 218 - neoplasm|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-2|16|320|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-3|16|393|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-4|16|435|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-5|16|437|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-6|16|447|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-7|16|485|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-8|16|493|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-9|16|526|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-10|16|569|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-11|16|607|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-12|16|615|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-13|16|619|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-14|16|648|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-15|16|661|Other deterministic changes|Whole body|MCDU/|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-16|16|665|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSL/  undifferentiated leukemia lymphoret.tissue,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-17|16|668|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-18|16|670|Other deterministic changes|Whole body|MCDU/|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-19|16|670|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-20|16|677|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-21|16|681|Other deterministic changes|Whole body|MCDU/|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-22|16|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-23|16|687|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWA: TAPS TO LUNG.|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-24|16|700|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-25|16|704|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-26|16|710|Neoplasia systemic|Haematolymphatic system|TLML/  Head/neck missing|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-27|16|714|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF LEFT FEMUR INVAS. OF THIGH MUSCLE.|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-28|16|717|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-29|16|719|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-30|16|729|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHCN/  Coagulative focal hepatitis,MPATH: 212 - inflammation|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-31|16|731|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-32|16|737|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-33|16|744|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-34|16|746|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-35|16|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-36|16|749|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-37|16|754|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-38|16|756|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-39|16|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-40|16|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ w/ leukemia.Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-41|16|771|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-42|16|778|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-43|16|793|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-44|16|796|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-45|16|796|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-46|16|798|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-47|16|801|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-48|16|805|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TULS/  Eye(s) missing Head/neck missing,MPATH: 551 - sarcoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-49|16|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases  trac spread to pleura.,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-50|16|806|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-51|16|812|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-52|16|817|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-53|16|821|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-54|16|823|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-55|16|825|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-56|16|827|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-57|16|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-58|16|831|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-59|16|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSL/  undifferentiated leukemia lymphoret.tissue,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-60|16|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-61|16|839|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-62|16|841|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-63|16|848|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-64|16|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-65|16|849|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-66|16|855|Neoplasia malignant|Endocrine system|TGAC/   Metastases  tgac metastasis to mediastinal tissues.|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-67|16|857|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-68|16|859|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Thorax missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-69|16|861|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-70|16|862|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-71|16|862|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|TSEC/ lt thorax-mammary gl area.,MPATH: 218 - neoplasm|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-72|16|868|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-73|16|869|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-74|16|869|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-75|16|873|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-76|16|875|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-77|16|876|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-78|16|880|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-79|16|883|Neoplasia unclassified|Other local manifestations and miscellaneus|THWS: TSEC TO LIVER.|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-80|16|885|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-81|16|885|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-82|16|888|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-83|16|890|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-84|16|896|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-85|16|900|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  MurineEye(s) missing Head/neck missing,MPATH: 212 - inflammation|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-86|16|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ with leukemia.,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-87|16|907|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-88|16|908|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-89|16|909|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-90|16|913|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases  Lymphoret.System tkac metast. to mediast. ln.Head/neck missing,MPATH: 549 - carcinoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-91|16|917|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-92|16|918|Other deterministic changes|Whole body|MCDU/|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-93|16|918|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-94|16|918|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-95|16|919|Neoplasia unclassified|Other local manifestations and miscellaneus|THWS: TSEC TO LIVER.|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-96|16|923|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-97|16|923|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/   Metastases Lung,MPATH: 242 - hemangiosarcoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-98|16|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-99|16|929|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-100|16|934|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-101|16|934|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-102|16|934|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-103|16|935|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF LEFT FEMUR INVAS. OF THIGH MUSCLE.|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-104|16|936|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-105|16|940|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-106|16|940|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF LEFT FEMUR INVAS. OF THIGH MUSCLE.|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-107|16|943|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXUO/ mesothelioma, fibrous of perit.,MPATH: 218 - neoplasm|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-108|16|947|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-109|16|949|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-110|16|950|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-111|16|959|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-112|16|963|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-113|16|964|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-114|16|966|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-115|16|970|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-116|16|974|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-117|16|977|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-118|16|980|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-119|16|983|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|TIEC/ stomach. Metastases  tiec in visc. peritoneum- kidney, liver, spleen, pancreas.,MPATH: 549 - carcinoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-120|16|983|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-121|16|985|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-122|16|987|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-123|16|987|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-124|16|990|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWK: TKAC METAST. TO MEDIAST. LN.|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-125|16|991|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-126|16|995|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-127|16|996|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-128|16|998|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ lt forelimb.|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-129|16|998|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-130|16|1007|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-131|16|1008|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-132|16|1009|Other deterministic changes|Whole body|MCDU/|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-133|16|1011|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-134|16|1011|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-135|16|1011|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-136|16|1012|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-137|16|1012|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-138|16|1014|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-139|16|1019|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-140|16|1021|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-141|16|1023|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-142|16|1026|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-143|16|1027|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-144|16|1027|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-145|16|1034|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-146|16|1035|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-147|16|1040|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXUO/ capillary angioma of lt ear margin.,MPATH: 218 - neoplasm|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-148|16|1041|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-149|16|1050|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-150|16|1053|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-151|16|1055|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-152|16|1057|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/   Metastases Lung|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-153|16|1058|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-154|16|1058|Neoplasia malignant|Adrenal gland  among endocrine systems|TAPS/   Metastases Lung|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-155|16|1065|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-156|16|1071|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-157|16|1073|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-158|16|1074|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-159|16|1074|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-160|16|1079|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-161|16|1080|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-162|16|1081|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-163|16|1081|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-164|16|1084|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases Liver,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-165|16|1084|Other deterministic changes|Whole body|MCDU/|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-166|16|1086|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-167|16|1089|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-168|16|1092|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-169|16|1096|Other deterministic changes|Whole body|MCDU/  Eye(s) missing Head/neck missing|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-170|16|1098|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-171|16|1102|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-172|16|1104|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-173|16|1106|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-174|16|1117|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-175|16|1121|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-176|16|1127|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-177|16|1131|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-178|16|1135|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-179|16|1137|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-180|16|1142|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-181|16|1145|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-182|16|1147|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-183|16|1160|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-184|16|1163|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-185|16|1163|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-186|16|1168|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-187|16|1174|Other deterministic changes|Whole body|MCDU/|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-188|16|1175|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-189|16|1181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-190|16|1184|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-191|16|1189|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-192|16|1191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-193|16|1211|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-194|16|1212|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ left femur. Metastases Lung Metastases  Muscle tbos of left femur invas. of thigh muscle.|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-195|16|1222|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-196|16|1239|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-197|16|1257|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-198|16|1258|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAC/  Carcinoma,MPATH: 218 - neoplasm|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-199|16|1263|n/a|n/a|n/a|
1003-26-16|n/a,X8|1|100|neutrons fission|0.2|grays|External exposure|code X8 1 fraction 20 m|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|200 records survival 797 ± 13 lifespan study|1003-26-16-200|16|1304|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-3|17|281|Other deterministic changes|Whole body|MCDU/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-6|17|414|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-7|17|442|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal,MPATH: 218 - neoplasm|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-9|17|448|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-10|17|453|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-11|17|463|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-15|17|515|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKVS/  ,MPATH: 551 - sarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-16|17|522|Other deterministic changes|Whole body|MCDU/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-17|17|526|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-18|17|526|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-25|17|556|Other deterministic changes|Whole body|MCDU/   Metastases Lung|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-26|17|562|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-29|17|577|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/ with infiltration of soft tiss.,MPATH: 242 - hemangiosarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-35|17|592|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ dorsal subcut in pelvic region.|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-37|17|599|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-44|17|635|Other deterministic changes|Whole body|MCDU/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-45|17|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSL/  undifferentiated leukemia lymphoret.tissue,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-46|17|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-47|17|644|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-48|17|653|Neoplasia benign|Bloodvessels among cardiovascular system|TCVO/ in adnexal fat in rt. pelvic region.|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-51|17|660|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal Metastases Lung tmab (mamm) to lung.,MPATH: 218 - neoplasm|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-53|17|660|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-54|17|661|Other deterministic changes|Whole body|MCDU/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-55|17|662|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-57|17|663|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-64|17|684|Neoplasia malignant|Other local manifestations and miscellaneus|TMSS/ TMSS/ TMSS/ TMSS/ musc of thigh.|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-65|17|691|Neoplasia malignant|Endocrine system|TGAC/   Metastases  tkac to adnexal conn. tiss. Metastases  tgac to eye orbit & skin of ear.|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-67|17|697|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVS/   Metastases  tovs into peritoneum.Head/neck missing,MPATH: 242 - hemangiosarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-71|17|704|Other deterministic changes|Whole body|MCDU/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-72|17|706|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-74|17|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-76|17|719|Neoplasia benign|Lower digestive tract,MA: 0000323 - gastrointestinal system|TIPO/ pylorus.,MPATH: 491 - polyp|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-77|17|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-79|17|729|Neoplasia malignant|Other local manifestations and miscellaneus|TSSS/ TSSS/ TSSS/ TSSS/ malignant melanoma of skin of inguinal region. Metastases  Lymphoret.System tsss of inguinal region invades regional nodes. Metastases Liver Metastases Lung|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-82|17|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Eye(s) missing Head/neck missing,MPATH: 268 - adenocarcinoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-84|17|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-86|17|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-87|17|743|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-88|17|745|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-91|17|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-93|17|758|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-95|17|764|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-96|17|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-97|17|769|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ perit.|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-98|17|769|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-100|17|772|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-101|17|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-102|17|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-109|17|797|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-113|17|808|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-117|17|816|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-118|17|817|Neoplasia unclassified|Central nervous system among nervous system|TNNB/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-124|17|827|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-125|17|828|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-126|17|829|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-127|17|829|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-130|17|834|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|TSEC/ lt lateral trunk.,MPATH: 218 - neoplasm|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-131|17|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Thorax missing Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-133|17|836|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-134|17|837|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-145|17|849|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-146|17|849|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-148|17|851|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|TNMS/ cerebrum.,MPATH: 551 - sarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-150|17|861|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-155|17|867|Other deterministic changes|Whole body|MCDU/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-158|17|871|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-160|17|873|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-162|17|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-164|17|877|Neoplasia systemic|Haematolymphatic system|TLML/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-165|17|879|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ melanosarcoma dermis-- lower lt quadrant. Metastases  Lung txus metast to lung. Metastases  txus metast to diap.|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-170|17|885|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-172|17|887|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-173|17|889|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-177|17|891|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ lt thigh. Metastases  Muscle tcvs invas of thigh musc.|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-182|17|896|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-184|17|899|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|TMRS/ back in thoracic region.,MPATH: 428 - rhabdomyosarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-186|17|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-187|17|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-188|17|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-192|17|914|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAC/  Carcinoma,MPATH: 218 - neoplasm|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-194|17|916|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-195|17|917|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-198|17|918|Neoplasia malignant|Endocrine system|TGAC/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-201|17|922|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-203|17|924|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases  tkac metast. to peritoneal surface of spleen, liver, contralat. kidney. Metastases Lung,MPATH: 549 - carcinoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-204|17|925|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-209|17|926|Other deterministic changes|Whole body|MCDU/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-210|17|927|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  Eye(s) missing Thorax missing Head/neck missing|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-214|17|933|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-219|17|940|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ femur & pelvis. Metastases  Kidney tbos of femur and pelvis to kidn & adre. Metastases Ovary|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-220|17|942|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-228|17|949|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-230|17|952|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-233|17|955|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/   Metastases  Lymphoret.System togc to renal node.Thorax missing Head/neck missing Eye(s) missing|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-234|17|955|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-237|17|961|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-238|17|961|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-239|17|962|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-242|17|965|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-250|17|979|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIA/  acute,MPATH: 212 - inflammation|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-251|17|980|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-253|17|983|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lower lumbar spine.|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-257|17|985|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ subcut. left inguinal region.|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-261|17|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-262|17|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-265|17|995|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-266|17|999|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-272|17|1004|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Lymphoret.System tgac to cn ln.|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-273|17|1005|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-274|17|1007|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-275|17|1007|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-283|17|1019|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|MTHR/  auricular|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-284|17|1021|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-286|17|1023|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-289|17|1030|Neoplasia unclassified|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUAC/  ,MPATH: 218 - neoplasm|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-290|17|1031|Other deterministic changes|Whole body|MCDU/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-291|17|1035|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-293|17|1037|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/   Metastases Lung Metastases  Lymphoret.System thac to abdominal node & mesenteric soft tissue.Head/neck missing Eye(s) missing|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-294|17|1037|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/   Metastases Liver|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-296|17|1037|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-297|17|1039|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TACC/   Metastases  Lymphoret.System tacc metast. to pt ln. Metastases Heart Metastases Lung Metastases LiverEye(s) missing Head/neck missing,MPATH: 549 - carcinoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-300|17|1041|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-304|17|1045|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-305|17|1045|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-311|17|1056|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-312|17|1056|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  Thorax missing Eye(s) missing Head/neck missing|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-315|17|1060|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-317|17|1061|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ base of spine. Metastases  Muscle tbos at base of spine invas. of muscle.|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-321|17|1069|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-322|17|1071|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-324|17|1074|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-329|17|1081|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MPNU/  Acute and subacute,MPATH: 212 - inflammation|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-331|17|1089|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-337|17|1103|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-339|17|1106|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-340|17|1107|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-341|17|1108|Other deterministic changes|Whole body|MCDU/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-344|17|1113|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-345|17|1114|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-348|17|1115|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-349|17|1116|Other deterministic changes|Whole body|MCDU/|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-352|17|1118|Neoplasia malignant|Adrenal gland  among endocrine systems|TAPS/   Metastases Lung|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-356|17|1122|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-366|17|1144|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ salivary gl. glandular carcinoma with intravasc. tumor emboli. Metastases  Lung txac (salivary gland) metast. to lung.,MPATH: 268 - adenocarcinoma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-367|17|1144|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-372|17|1156|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-373|17|1157|Neoplasia benign|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVO/   Metastases Lung,MPATH: 240 - hemangioma|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-382|17|1194|n/a|n/a|n/a|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-383|17|1204|Neoplasia malignant|Adrenal gland  among endocrine systems|TAPS/   Metastases Lung|
1003-26-17|n/a,X9|1|100|neutrons fission|0.4|grays|External exposure|code X9 1 fraction 20 m|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 753 ± 16 lifespan study|1003-26-17-389|17|1249|n/a|n/a|n/a|
